Synthesis, characterization and inertness studies of gallium(III) and indium(III) complexes of dicarboxymethyl pendant-armed cross-bridged cyclam by Terova, Orjana
University of New Hampshire
University of New Hampshire Scholars' Repository
Master's Theses and Capstones Student Scholarship
Fall 2008
Synthesis, characterization and inertness studies of




University of New Hampshire, Durham
Follow this and additional works at: https://scholars.unh.edu/thesis
This Thesis is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has been
accepted for inclusion in Master's Theses and Capstones by an authorized administrator of University of New Hampshire Scholars' Repository. For
more information, please contact nicole.hentz@unh.edu.
Recommended Citation
Terova, Orjana, "Synthesis, characterization and inertness studies of gallium(III) and indium(III) complexes of dicarboxymethyl
pendant-armed cross-bridged cyclam" (2008). Master's Theses and Capstones. 400.
https://scholars.unh.edu/thesis/400
SYNTHESIS, CHARACTERIZATION AND INERTNESS STUDIES OF 
GALLIUM(III) AND INDIUM (III) COMPLEXES OF DICARBOXYMETHYL 
PENDANT-ARMED CROSS-BRIDGED CYCLAM 
BY 
ORJANA TEROVA 
B.S. Worcester State College, 2004 
THESIS 
Submitted to the University of New Hampshire 
In Partial Fulfillment of 
the Requirements of the Degree of 




UMI Number: 1459517 
INFORMATION TO USERS 
The quality of this reproduction is dependent upon the quality of the copy 
submitted. Broken or indistinct print, colored or poor quality illustrations and 
photographs, print bleed-through, substandard margins, and improper 
alignment can adversely affect reproduction. 
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if unauthorized 
copyright material had to be removed, a note will indicate the deletion. 
® 
UMI 
UMI Microform 1459517 
Copyright 2008 by ProQuest LLC. 
All rights reserved. This microform edition is protected against 
unauthorized copying under Title 17, United States Code. 
ProQuest LLC 
789 E. Eisenhower Parkway 
PO Box 1346 
Ann Arbor, Ml 48106-1346 
This thesis has been examined and approved. 
Thesis Director, Dr. Edward H. Wong 
Professor of Chemistry 
Dr. uasryK. weisman 
Professjor of Chemistry 
Dr. Roy P. Planalp 




I dedicate this thesis to my husband Ilia for his continuous love and support. I 
would also like to dedicate this work to my amazing parents and brother for their 
inspiration, love and principles that shaped me into who I am today. 
in 
ACKNOWLEDGMENT 
It will be very difficult to express in a paragraph the amount of gratitude that I 
feel for the people who helped me achieve this degree. Dr. Wong has had the most 
impact on me during my time here at UNH. I will forever have the deepest admiration 
and respect for him. He portrays the definition of a true mentor and I will always be 
grateful for his endless patience, guidance and genuineness. His passion for chemistry 
and innovative research has continuously inspired and motivated me. On a lighter note I 
will miss our conversations about sports, music, culture and life in general. Also, I have 
been fortunate to study under the guidance of Dr. Gary Weisman. I will always value his 
enthusiasm for teaching and research. I truly feel privileged to have studied under the 
guidance of these two great scientists. 
I am thankful to Dr. Roy Planalp for his interest and his constructive suggestions 
about my research. I would like to thank all other UNH faculty who have played a very 
important role during my time here. 
I can truly say that I have established a lifelong friendship with Antoinette 
Odendaal and Abraham Tucker. I want to thank them for their true values and character 
and for all the good times. 
I would like to acknowledge all the graduate students in the department and the 
Wong-Weisman group members for their help and support. 
I must recognize the UIC staff (Kathy Gallagher, Pat Wilkinson, and John 
Wilderman) and our chemistry librarian Bob Constantine for their help. Finally, I would 
like to give a special thanks to Cindi Rohwer and Peg Torch for all their help during my 
time at UNH. 
iv 
TABLE OF CONTENTS 
DEDICATION iii 
ACKNOWLEDGMENT iv 
TABLE OF CONTENTS v 
LIST OF FIGURES viii 
LIST OF SCHEMES xii 
LIST OF TABLES xiii 
ABSTRACT xiv 
CHAPTER I. INTRODUCTION 1 
1. Coordination chemistry of tetraazamacrocycles 1 
1.1 Cross-bridged tetraamines and their coordination chemistry 4 
1.2 Ga(III) and In(III) chemistry and their relevance as diagnostic tools 6 
1.2.1 Coordination chemistry of Ga(III) and In(III) cyclam, cyclen and their 
derivatives 10 
1.2.2 Coordination chemistry of Ga(III) and In(III) with cross-bridged 
tetraamines 12 
1.3 Research goals 16 
CHAPTER II. Ga(III) and In(III) complexation with a dicarboxylate-armed cross-bridged 
cyclam ligand 17 
2.1 Introduction 17 
2.2 Synthesis and characterization 19 
2.2.1 Synthesis of the Ga(III) complex with ligand 7 19 
2.2.2 Synthesis of the In(III) complex with ligand 7 22 
2.2.3 Solution *H and 13C {'H} NMR data 24 
2.2.4 X-ray structural data 37 
2.3 Conclusion 42 
CHAPTER III. Kinetic inertness studies of Ga-CB-TE2A and In-CB-TE2A 44 
3.1 Introduction 44 
3.2 Results and discussion 45 
3.2.1. Kinetic inertness studies of Ga(III) and In(III) complexes with ligand 7 45 
3.3 Summary and discussion 63 
3.4 Conclusion 64 
3.5 Experimental section for kinetic studies 65 
CHAPTER IV. Optimizing microwave-assisted Cu(II), Ga(III) and In(III) complexations 
with cross-bridged tetraamine ligands 5-7 67 
4.1 Introduction 67 
4.2 Synthesis of Cu(II) complexes with ligands 5-7 71 
4.3 Synthesis of Ga(III) and In(III) complexes with ligand 5 82 
4.4 Conclusion 86 
VI 
CHAPTER V. EXPERIMENTAL SECTION 88 
APPENDIX 94 
LIST OF REFERENCES 107 
vn 
LIST OF FIGURES 
Figure Page 
Figure 1.01 Common tetraazamacrocycles 2 
Figure 1.02 Five possible trans-configurations for cyclam 3 
Figure 1.03 Four possible configuration for cyclen 3 
Figure 1.04 Cis coordination modes for cyclam 3 
Figure 1.05 Cross-bridged tetraamines 5 
Figure 1.06 Cis-V coordination geometry of cross-bridged ligands 
and their metal complexation 5 
Figure 1.07 Ligand 7-based bioconjugate 6 
Figure 1.08 A schematic representation of a radiopharmaceutical 8 
Figure 1.09 Ga(III) and In(III) complexes with DOTATOC 11 
Figure 1.10 Ga(III) and In(III) complexes of D03 A-xy-TTP 12 
Figure 1.11 X-ray structure of [GaCl2-CB-Cyclam]+ 13 
Figure 1.12 X-ray structure of [InBr2-CB-cyclam]+ 13 
Figure 1.13 X-ray structure of [InBr2-CB-cyclen]+ 14 
Figure 1.14 X-ray structure of [Ga-CB-D02A]+ 15 
Figure 2.01 H2-CB-TE2A, a dicarboxylate cross-bridged cyclam ligand 17 
Figure 2.02 [H NMR (in D20 using MeCN as reference at 2.06 ppm) 
oftGa^J^CV 24 
Figure 2.03 13C {]H} NMR (in D20 using MeCN as reference at 1.47 ppm) of 
[Ga-7]+N03~ 25 
Figure 2.04 HSQC NMR (in D20 using MeCN as reference) of [Ga-7]+N03~ 25 
vm 
Figure 2.05 !H NMR (in D20 using MeCN as reference at 2.06 ppm) 
of[In-7]N03at25°C 26 
Figure 2.06 *H NMR VT studies (in D2O using MeCN as reference at 2.06 ppm) 
of[In-7]N03 27 
Figure 2.07 *H NMR (in D20 using MeCN as reference at 2.06 ppm) of [In-7C1] 
at 25°C 28 
Figure 2.08 ,3C {lU} NMR (in D20 using MeCN as reference at 1.47 ppm) 
of[In-7Cl]at25°C 29 
Figure 2.09 Variable temperature *H NMR (in D20 using MeCN as reference at 
2.06ppm)of[In-7Cl] 29 
Figure 2.10 Variable temperature 13C {'H} NMR (in D20 using MeCN 
as reference at 1.47 ppm) of [In-7C1] 30 
Figure 2.11 !H NMR (in D20 using MeCN as reference at 2.06 ppm) 
of[In-7]PF6at25°C 31 
Figure 2.12 13C {'H} NMR (in D20 using MeCN as reference at 1.47 ppm) 
of[In-7]PF6at25°C 31 
Figure 2.13 IR(KBr) spectrum of [Ga-7]N03 32 
Figure 2.14 FAB+ Mass spectrum of [Ga-7]NC-3 32 
Figure 2.15 Simulated spectrum of [Ga-7]N03 33 
Figure 2.16 IR(KBr) spectrum of [In-7C1] 33 
Figure 2.17 FAB+ Mass spectrum of [In-7C1] 34 
Figure 2.18 Simulated spectrum of [In-7C1] 34 
Figure 2.19 IR(KBr) spectrum of [In-7]PF6 35 
Figure 2.20 FAB+ Mass spectrum of [In-7]PF6 36 
Figure 2.21 X-ray structure of [Ga-7]+ 38 
Figure 2.22 X-ray structure of [In-7C1] 40 
Figure 2.23 X-ray structure of [In-7]+ 40 
IX 
Figure 3.01 *H NMR spectra in 1.02 N DC1/D20: a) Ligand 7 in 1.02 N DC1/D20 
at 90°C, b) Complex Ga-7 in 1.02 N DC1/D20 at 90°C, 
c) Ligand 7 in 1.02 N DC1/D20 at 25°C, d) Complex Ga-7 in 1.04 N 
DC1/D20 at 25°C after 11 months 46 
Figure 3.02 ]H NMR spectra in 5.04 N DC1/D20 at 25°C: a) Complex Ga-7 
b) Ligand 7 after 11 months 47 
Figure 3.03 ]H NMR spectra of Ga-7 complex in 4.97 N DC1/D20 at 90°C, 
time (hours) 48 
Figure 3.04 Plot of ln(N/No) vs time(hours) of complex Ga-7 
"decomplexation" data in 4.97 N DC1/D20 at 90°C 49 
Figure 3.05 Top spectrum: !H NMR of sample spiked with free ligand 7 51 
Figure 3.06 13C NMR of sample spiked with free ligand 7 51 
Figure 3.07 MALDI mass spectrum of complex Ga-7 in 4.97 N DC1/D20 
prior to spiking with free ligand 7 52 
Figure 3.08 MALDI mass spectrum of complex Ga-7 in 4.97 N DC1/D20 
after spiking the sample with free ligand 7 52 
Figure 3.09 Simulated mass spectrum of complex Ga-7 after H/D exchange 53 
Figure 3.10 MALDI mass spectrum of complex Ga-7 in 5.03 M HC1 53 
Figure 3.11 !H NMR spectra of complex Ga-7 in 9.01 N DC1/D20 
at 90°C, time (hours) 54 
Figure 3.12 MALDI mass spectrum of Ga-7 complex in 9.01 N DC1/D20 55 
Figure 3.13 Plot of ln(N/No) vs time(hours) of complex Ga-7 
"decomplexation" data in 9.01 N DC1/D20 at 90°C 55 
Figure 3.14 Kinetic inertness studies of Ga-7 in 1.3 N NaOD 
at 25°C: a) Ligand 7, b) Ga-7 complex 56 
Figure 3.15 !H NMR spectra of [In-7C1] in 1.03 N DC1/D20 at 25°C, 
time (minutes) 58 
Figure 3.16 Plot of ln(N/No) vs time(minutes) of [In-7C1] 
decomplexation data in 1.03 N DC1/D20 at 25°C 59 
Figure 3.17 MALDI mass spectrum of complex [In-7C1] in 1.03 N DC1/D20 
after 3 months 59 
x 
Figure 3.18 !H NMR spectra of [In-7]PF6 in 1.02 N DC104/D20 
at 25°C, time (hours) 61 
Figure 3.19 Plot of ln(N/No) vs time(hours) of [In-7]PF6 "decomplexation" 
data in 1.02 N DC104/D20 at 25°C 62 
Figure 3.20 MALDI mass spectrum of complex [In-7]PF6 in 
1.02NDClO4/D2O 62 
Figure 4.01 Cross-bridged ligands 5-7 71 
Figure 4.02 Visible electronic absorption spectrum of Cir7 in aqueous 
citrate buffer 73 
Figure 4.03 Chromatograms of Cu-7 with: (left) 1:10 Cu(II)/Ligand ratio, 
(middle) 1:100 Cu(II)/Ligand ratio, (right) 1:1000 
Cu(II)/Ligand ratio with retention time of Cu-7 is 3.9 minutes, 
the first peak corresponds to the citrate 75 
Figure 4.04 Visible electronic absorption spectrum of CuCl2"6 in 
aqueous citrate buffer 77 
Figure 4.05 Chromatograms of CuCl2-6 with: (left) 1:10 
Cu(II)/Ligand ratio, (middle) 1:100 Cu(II)/Ligand ratio, 
(right) 1:1000 Cu(II)/Ligand ratio with retention time 
of Cu-7 is 9.5 minutes, the first peak corresponds 
to the citrate 79 
Figure 4.06 UV-Vis spectrum of Q r 5 in aqueous citrate buffer 81 
Figure 4.07 *H NMR spectrum (in D20 using MeCN as reference 
at2.06ppm)of[In-5Cl] 84 
Figure 4.08 X-ray structure of [In-5Cl]-2NaPF6 84 
XI 
LIST OF SCHEMES 
Scheme Page 
Scheme 1.1 Indirect route to synthesize [In-CB-TE2A] 15 
Scheme 1.2 General synthetic scheme to synthesize ligands 4, 5, 6, and 7 16 
Scheme 2.1 Ga(III) complexation with ligand 7 19 
Scheme 2.2 Previous attempts of Ga(III) complexation using 
anhydrous conditions and aprotic solvent 20 
Scheme 2.3 Attempted Ga(III) complexation in buffered aqueous media 21 
Scheme 2.4 Ga(III) complexations with ligand 7 as TFA salt 22 
Scheme 2.5 In(III) complexation with 7 using In(NC>3)3 22 
Scheme 2.6 In(III) complexation with 7 using InCl3 23 
Scheme 2.7 Anion exchange using NH4PF6 23 
Scheme 2.8 Possible dynamic behavior of [In-7C1] 28 
Scheme 4.1 Cu(II) complexation with ligand 7 using 
microwave-assisted conditions 71 
Scheme 4.2 Cu(II) complexation with ligand 6 using 
microwave-assisted conditions 76 
Scheme 4.3 Cu(II) complexation with ligand 5 using 
microwave-assisted conditions 80 
Scheme 4.4 Ga(III) complexation with ligand 5 using 
microwave-assisted conditions 82 
Scheme 4.5 In(III) complexation with ligand 5 using 
microwave-assisted conditions 83 
Scheme 4.6 Counter ion-exchange using NH4PF6 84 
xn 
LIST OF TABLES 
Table Page 
Table 1.1 Isotopes of gallium and indium 9 
Table 2.1 IR data of the Ga(III) and In(III) complexes of 7 36 
Table 2.2 Selected bond angles (deg) and bond lengths (A) of [Ga-7]N03 38 
Table 2.3 Selected bond angles (deg) and bond lengths (A) of [In-7C1] 41 
Table 2.4 Selected bond angles (deg) and bond lengths (A) of [In-7]PF6 42 
Table 3.1 Half-lives of selected metal complexes with 
cross-bridged tetraamines in acidic media 45 
Table 3.2 Data for figure 3.04 a, b 49 
Table 3.3 Data for figure 3.16 58 
Table 3.4 Data for figure 3.19 61 
Table 4.1 Unsuccessful attempts for Cu-7 complexations at 
lower temperatures using microwave assistance 73 
Table 4.2 Unsuccessful attempts for Cu-6 complexations at 
lower temperatures using microwave assistance 77 
Table 4.3 Unsuccessful attempts for Cu-5 complexations at 
lower temperatures using microwave assistance 80 
Table 4.4 Selected bond angles (deg) and bond lengths (A) of [In-5C1] 86 
xm 
ABSTRACT 
SYNTHESIS, CHARACTERIZATION AND INERTNESS STUDIES OF 
GALLIUM(III) AND INDIUM(III) COMPLEXES OF DICARBOXYMETHYL 
PENDANT-ARMED CROSS-BRIDGED CYCLAM 
BY 
ORJANA TEROVA 
University of New Hampshire, September, 2008 
Radiopharmaceuticals are drugs based on radioisotopes designed for diagnostic 
and therapeutic purposes. Radiometal complexes as radiopharmaceuticals for medical 
imaging have received increased attention in the past decades. Coordination chemistry 
plays an important role in the design of these target-specific radiopharmaceuticals. It is 
very important to correlate all aspects of a radiometal's coordination chemistry with its in 
vivo behavior. Macrocyclic chelators are ligands that form stable metal complexes. In the 
1990s Weisman, Wong et al. developed a new class of tetraazamacrocycles featuring 
ethylene cross-bridges linking nonadjacent nitrogens. These cross-bridged chelators form 
very inert complexes with a variety of metal cations. While most attention has been paid 
to their Cu(II) complexes, Ga(III) and In(III) are also potential radiometal candidates. In 
this work, previously inaccessible Ga(III) and In(III) complexes of a dicarboxylate cross-
bridged cyclam ligand have been synthesized for the first time. Their kinetic inertness 
has been investigated by acid decomplexation studies. Finally, Cu(II) complexations 




1. Coordination chemistry of tetraazamacrocycles 
Polydentate macrocyclic ligands incorporate their donor atoms into the cyclic 
backbone. Macrocyclic ligands contain a minimum of nine atoms; at least three of which 
must be donors.1 Macrocyclic host-guest complexation chemistry has been developed 
extensively. There has been intense investigation of this for a number of fundamental 
biological systems due to the enhanced kinetic and/or thermodynamic stabilities of the 
resulting metal complexes. " This has provided a great deal of impetus for the 
o n 
exploration of the metal-coordination chemistry of these systems. ' 
Tetraazamacrocycles are a class of macrocyclic ligands that contains nitrogen 
donor atoms (Figure 1.01).12 These ligands can form metal complexes with a variety of 
metal cations including alkali, alkaline earth, transition metals, and lanthanides.4'10 
Metal complexes of macrocyclic tetraamines can potentially adopt several 
1 1 1 9 
configurationally isomeric cis- or £ra«s-coordination-modes. ' Increased 
thermodynamic stability and kinetic inertness are observed for the complexes of cyclic 
ligands versus the acyclic analogues.13 This increased stability is due to the macrocyclic 
effect as defined by Cabbiness and Margerum.13 As a result of their kinetic inertness, 
tetraazamacrocycle complexes have a wide variety of potential and realized applications 
in medical sciences.14'15 
1 
/-* n n 
NHHN.
 NH HN /NH HN 
NHHN ^NHHN NH HN 
Figure 1.01: Common tetraazamacrocycles: Cyclen 1, Homocyclen 2, Cyclam 3 
Cyclam metal complexes can adopt any of eight possible trans- or cis- folded 
configurations, depending on the arrangement at the nitrogen atoms (Figures 1.02, 
1.04).11'16"19 The naming of the isomers is based on the nomenclature of Bosnich et al. 
The ligand can adopt any of these configurations about the metal depending on the size of 
the metal ion, because the selectivity of these ligands is mostly based on size match 
selectivity.' It has been shown that the trans-Ill configuration is most frequently 
obtained when the macrocycle is coordinated to a metal ion that has the suitable size (i.e 
Cu(II). When the metal ion is too large, configurations such as trans-l (e.g. Hg(II), 
Cd(II) ) or ds-V (e.g. Pb(II)) have been observed.16,20 
In general, cyclen metal complexes adopt the trans-l configuration (Figure 1.03) 
as supported by crystallographic data, as the trans-Ill configuration has a smaller cavity 
which is only suitable for very small metal cations like Be . This configuration is higher 
in energy than the trans-l, which means that trans-Ill metal complexes of cyclen most 
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Figure 1.02: Five possible trans-configurations for cyclam 
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Figure 1.03: Four possible configurations for cyclen 
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Figure 1.04: Cis coordination modes for cyclam 
3 
Some of the many realized and potential applications of cyclam complexes 
include catalysis, anti-HIV drugs as well as biomimetic chemistry. ' ' ' ' There has 
also been a great deal of research in investigating tetraazamacrocycles as potential 
bifunctional chelators in radiopharmaceutical-based applications due to the high stability 
? 1 99 
of their complexes. ' A more detailed discussion of this will be given in Section 1.2. 
1.1. Cross-bridged tetraamines and their coordination chemistry 
In 1990 Weisman, Wong and co-workers were the first to report a class of novel 
cross-bridged tetraamine ligands, (Figure 1.05) which contain a bridging ethylene unit 
connecting two nonadjacent nitrogens. 3'24 The ligand itself is quite flexible, but when it 
is coordinated with smaller metal cations, it adopts a cis-V folded coordination geometry 
9*1 "KC\ 
(Figure 1.06). " The cross-bridged tetraamines have been designed to adopt low 
energy conformations in which all four nitrogen lone pairs are convergent upon a 
cleft.25"30 This is ideal for the complexation of smaller metal cations (e.g. Cu(II), Zn(II), 
Ga(III) with ionic radii 76 pm to 88 pm, data for coordination number of six).25~30 The 
cross-bridged ligands can further be functionalized with various pendant arms, which 
allows for fine tuning of metal coordination, completion of a coordination sphere, and 
neutralizing the positive charge of the metal cation with ionizable functionalities, all of 
which enhances the complex stability. 
4 
NH N 
\ 1 0 U 
. . . . oe 
Q o 
NH V
 Q ^ O N N / N N 
e 
Figure 1.05: Cross-bridged tetraamines: CB-Cyclen 4, CB-D02A 5, 
CB-Cyclam 6, CB-TE2A 7, diBn-Me2-CB-Cyclam 8 
X D s ZIP? + 
R - M ^ R CM*, 
Figure 1.06: Cis-V coordination geometry of cross-bridged ligands and their metal 
complexation 
Among the transition metals used to complex several cross-bridged cyclam- and 
1 1 
cyclen-based ligands that have been investigated by Niu are Cu(II), Zn(II), and Hg(II). 
Also Ga(III) metal complexes of ligands 5 and 6 and In(III) complexes of ligands 4 and 6 
were synthesized by Niu. All of these display the favored cis-V folded coordination 
geometry.25"30 
Recently we have been interested in Cu(II), In(III), and Ga(III) complexes of 
these crossed-bridged ligands due to their potential as bifunctional chelators (BFCs) in 
radiometal-based pharmaceutical applications. 2'33 It has been confirmed that 
crossed-bridged ligand 7, CB-TE2A, is a valuable bifunctional chelator (BFC) for 64Cu 
5 
(Figure 1.07).32'33 CB-TE2A has been bioconjugated to the somatostatin analogue Y3-
TATE and superior behavior of its 64Cu-labeled bioconjugate has been observed as a 
result of its improved in vivo stability. ' 
Figure 1.07: Ligand 7-based bioconjugate 
1.2 Ga(III) and In(III) metal ions and their relevance in radiopharmaceutical 
applications 
The use of radiometal complexes as radiopharmaceuticals for medical imaging is 
a relatively new area that is rapidly growing.21'22 Metallic radionuclides are of great 
interest because of their wide range of nuclear properties as well as their well established 
coordination chemistry. In 1959, Brookhaven National Laboratory developed the first 
9
 Mo/ mTc generator, which marked a significant milestone for subsequent development 
of small molecule 9mTc complex radiopharmaceuticals. 6 
Coordination chemistry plays an important role in the design of target-specific 
radiopharmaceuticals. There are three general strategies in the radiopharmaceutical 
design: the integrated approach, the bifunctional approach (Figure 1.08), and the 
peptide-hybrid approach. 5" ° In all three approaches inorganic chemistry is very 
significant, because it is the radiometal that distinguishes radiopharmaceuticals from 
6 
traditional therapeutic pharmaceuticals. When designing metal complex-based imaging 
agents it is very important to correlate aspects of coordination chemistry with subsequent 
in vivo behavior. Some of the factors that should be considered are the redox properties, 
stability, stereochemistry, charge and solubility of the metal complex.34'35 
There are three imaging modalities used in radiology: gamma scintigraphy, 
Positron Emission Tomography (PET), and Magnetic Resonance Imaging (MRI). Metal 
complexes are used in all three imaging modalities. ' For gamma scintigraphy and 
PET, radiopharmaceuticals labeled with metal radionuclides are injected into patients to 
diagnose medical problems such as cancer, infection, kidney and liver abnormalities, and 
cardiological and neurological disorders.34' 7"40 There are several significant 
considerations when designing a radiopharmaceutical. These factors include the half-life 
of the radiometal, the mode of decay, and the cost and availability of the isotope. ' 
Radiometals for coordination complex-based radiopharmaceuticals in PET and gamma 
scintigraphy range in half-lives from about 10 min to several days.34'36 The desired half-
life depends on the time required for the radiopharmaceutical to localize at the target 
tissue. Most of the radionuclides used in nuclear medicine for diagnostic imaging decay 
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CB-TE2A acts as a BFC where it complexes to a 
64Cu radionuclide and also has a functional group 
to attach the chelated metal to a biomolecule 
Figure 1.08: A schematic representation of a radiopharmaceutical. CB-
TE2A binds to 64Cu and is linked to a targeting molecule, such as a protein or 
peptide 
Our interest in the coordination chemistry of gallium is in large part due to the 
potential application of 68Ga-labeled bioconjugates as PET imaging agents.34"4 We are 
also interested in exploring the coordination chemistry of indium due the wide use of 
i nIn in gamma scintigraphy.37"40 
The most relevant oxidation state of gallium and indium for radiopharmaceutical 
• 5 . 
chemistry is +3, which is their most prevalent oxidation state in aqueous solution. In 
and Ga3+ are hard acids and due to their high charge density they prefer chelators with 
hard donors such as amine-N, carboxylate-O, and phenolate-O. Depending on the ligand, 
8 
gallium can adopt coordination numbers of 3,4, 5, and 6, but to maintain its in vivo 
stability Ga is often six-coordinated in a chelator. " Indium(III) is a larger cation than 
,3+ Ga and can adopt up to 8-coordination geometries. Their aqueous chemistry is 
dominated by their ability to form strong complexes with OH" ion. Their hydrated Ga 3+ 
,3+ and In forms are only stable under acidic conditions, 37-40 Once the pH is raised above 
3, insoluble In(OH)3 and Ga(OH)3 will form. This is a great challenge that we face 
(particularly at pH>3) during radiolabeling in aqueous solution. Another important 
aspect that should be considered is that both Ga3+ and In3+ bind to transferrin protein (Tf) 
in the blood with high affinity, thus this protein has an important effect on the 
biodistribution of these radionuclides.36"4 Tf binding must be taken into account when 
designing new radiopharmaceuticals. Thus the majority of reported gallium and indium 
complexes employed as radiopharmaceuticals have very high thermodynamic stability or 
are kinetically inert to exchange with transferrin in vivo.36_4 Gallium and indium 



















Table 1.1: Isotopes of gallium and indium. 
9 
Gallium has three radioisotopes with decay characteristic suitable for PET 
imaging or gamma scintigraphy (Table 1.1). 67Ga is more utilized due to its ability to 
identify both inflammations and soft tissue tumors.35"40 68Ga is interesting because it is a 
positron emitter and thus used for PET imaging giving higher resolution and sensitivity. 
Also this radionuclide is generator produced with a very long-lived parent. 66Ga is also a 
positron emitter, but it has only a moderate positron efficiency.35"40 
A very important and the only clinically-used gallium radiopharmaceutical is 
Ga-labeled citrate/transferrin. " This radiopharmaceutical exchanges in vivo with 
transferrin and is widely used for the clinical diagnosis of certain types of neoplasms, 
such as Hodgkin's disease, lung cancer, melanoma, and leukemia.37"40 
The most widely-used radioisotope of indium is In (Table 1.1) which decays 
by electron capture with subsequent emission of gamma photons, suitable for gamma 
scintigraphy. n ]In -DTPA-Octreotide (Octreoscan) was approved by the FDA in 1994 as 
a diagnostic imaging agent for neuroendocrine tumors. 
1.2.1 Coordination chemistry of Ga(III) and In(III) of cyclam, cyclen and their 
derivatives 
In section 1 the possible coordination geometries of cyclam and cyclen were 
described. There are actually few Ga(III) and In(III) complexes of cyclam, cyclen or 
their derivatives that are fully characterized in the literature. In 1999 Macke and 
coworkers reported the Ga(III) and In(III) complexes of a DOTA-functionalized 
somatostatin analogue, DOTATOC (Figure 1.09).41 The gallium complex adopts a 
pseudo-octahedral geometry with a c/s-folded macrocyclic unit in a [2424] 
10 
41 
conformation. The larger indium cation complexes in an eight-coordinated fashion in 
the solid state, but becomes seven-coordinate in solution.41 
Recently Liu and coworkers reported the crystal structures of In(III) and Ga(III) 
complexes of-D03A-xy-TPP (Figure 1.10).42 In the indium complex the ligand acts as 
a heptadentate ligand and the coordination geometry is a monocapped octahedron. In the 
gallium complex the coordinated ligand is hexadentate due to its smaller size and the 
complex coordination geometry is described as distorted octahedral.42 
u 
























Figure 1.09: Ga(III) and In(III) complexes with DOTATOC 
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Figure 1.10: Ga(III) and In(III) complexes of D03A-xy-TPP 
1.2.2 Coordination chemistry of Ga(III) and In(III) with cross-bridged tetraamines 
Weijun Niu was the first person to synthesize gallium and indium complexes of 
cross-bridged tetraamines. Specifically, Niu was able to prepare and fully characterize 
the Ga(III) complexes of ligands 5 and 6 and the In(III) complexes of ligands 4, and 6. 
The [GaCl2-CB-Cyclam]Cl complex (Figure 1.11) revealed a cis-V coordination 
geometry where the conformation of the ligand is a [2323]/[2323] distorted diamond 
"X1 
lattice. Gallium fits well into the ligand molecular cleft displaying a distorted 
octahedral coordination sphere. [InBr2-CB-Cyclam]Br (Figure 1.12) also has a distorted 
octahedral geometry but in contrast to the [GaCl2-CB-Cyclam]Cl complex, the larger 
In(III) does not fit as well in the ligand cleft. [InBr2-CB-Cyclen]Br (Figure 1.13) has also 
been synthesized by Niu and it can be observed from the crystal structure that the 
geometry is pseudo-octahedral where In(III) has an even more distorted coordination 
12 
geometry than in [InBr2-CB-Cyclam]Br.3! This is a combination of both the large size of 
the In(III) cation along with the smaller ligand cavity in cyclen-based macrocycles. 
Figure 1.12: X-ray structure of [InBr2-CB-Cyclam]+ 
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Figure 1.13: X-ray structure of [InBr2-CB-Cyclen]+ 
The structure of the [Ga-CB-D02A]NC>3 complex (Figure 1.14) again reveals a 
T 1 
distorted octahedral geometry around the Ga(III) coordination sphere. These results 
show that the smaller Ga(III) cation is a better fit for the cross-bridged chelators, whereas 
the larger In(III) yielded more distorted complexes. Wei-Chih Lee was able to synthesize 
[In-CB-D02A]C1 following the procedure developed by Niu for the [Ga-CB-D02A] 
complex.43 Direct attempts by Lee to synthesize complexes of In(III) and Ga(III) with 7 
resulted only in protonated ligand. An indirect route was developed by Lee where 
[InBr2-CB-Cyclam]Br was alkylated with ethyl bromoacetate to synthesize [InBr2-Et2-
CB-TE2A]Br (Scheme l.l).43 This was followed by hydrolysis of the two acetate arms 
[InBr2-Et2-TE2A] to obtain [In-CB-TE2A]+, which was not fully characterized. However 
Lee's attempts to indirectly synthesize [Ga-CB-TE2A]+ this way were not successful. 
14 
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Scheme 1.1: Indirect route to synthesize [In-CB-TE2A] 
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Figure 1.14: X-ray structure of [Ga-CB-D02A]H 
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1.3 Research Goals 
The focus of this thesis is the synthesis and characterization of Ga(III) and In(III) 
complexes of dicarboxylate cross-bridged tetraamines. As mentioned above, Ga(III) and 
In(III) tend to form very stable complexes which makes them interesting for 
radiopharmaceutical-based applications. The in vivo stability of the complexes is a very 
important aspect; thus acid-decomplexation studies have been performed to gauge their 
kinetic inertness. The starting materials for preparing the desired complexes were 
synthesized according to previous procedures developed in the Weisman-Wong group 
o r 
(Scheme 1.2). We have expanded our efforts into exploring microwave-assisted 
coordination chemistry and several complexation reactions have been investigated using 
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m=0, 1 n=0, 1;R=CH2C02/-Butyl 
(a) aq Glyoxal, MeCN, 50-60°C; (b) BnBr, MeCN; 
(c)xsNaBH4, 95% EtOH, microwave assisted; (d) aq HC1; (e) aq NaOH/PhH; 
(f) H2, 10% Pd/C,HOAc; (g)NaOH/PhH; (h)BrCH2C02/-Butyl 
Scheme 1.2: General synthetic scheme to synthesize ligands 4, 5, 6, and 7 
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CHAPTER II 
GALLIUM(III) AND INDIUM(III) COMPLEXATIONS WITH A 
DICARBOXYLATE-ARMED CROSS-BRIDGED CYCLAM LIGAND 
2.1 Introduction 
As discussed in Chapter I our interest in the complexation of Ga(III) and In(III) 
with ligand 7 (Figure 2.01) is due to the ability of this ligand to form kinetically inert 
complexes which can be used in radiopharmaceutical-based applications. Niu was the 
first to synthesize a Ga(III) complex with ligand 5. Lee successfully synthesized the 
In(III) complex with ligand 5, but no X-ray structural data were obtained.43 These were 
the only two Ga(III) and In(III) metal complexes with dicarboxylate-armed cross-bridged 
ligands when this work was undertaken. Acid decomplexation studies reveal remarkable 
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Figure 2.01: H2-CB-TE2A 7, a dicarboxylate cross-bridged cyclam ligand 
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There are many factors that will influence the ease of metal complexation with 
cross-bridged macrocycles. These include the nature of the solvent, steric and 
electrostatic effects as well as the ligand protonation state.47"58 One significant challenge 
to keep in mind is that in aqueous solution Ga and In tend to form the insoluble 
hydroxide species if the pH is higher than 3. This is a major limitation, which means that 
for effective complexation the reactions need to be performed at pH 3 or lower. This 
challenge now couples with another, because we must consider ligand protonation since 
under these conditions the ligand is at least twice inside-protonated. Metal complexation 
will be more challenging as a consequence of the additional electrostatic repulsion 
present.47"58 Solvent exchange can control formation kinetics which involves substitution 
of a ligand for a coordinated solvent molecule. Thus the water exchange rates for the 
"5 i -> I An c o 
hydrated Ga and In may be factors. " The water exchange rates for these metal 
cations are relatively slow (rate constants are 10 s" for Ga and 10 s" for In ), which 
further slows down the metal complexation.5 It is imperative to keep in mind all of these 
factors and challenges when investigating Ga + and In3+ complexations with ligand 7. 
Weijun Niu and Wei-Chih Lee attempted Ga(III) and In(III) complexations with ligand 7 
under varying temperature, reaction times, aprotic solvents and strictly anhydrous 
conditions, but all their attempts resulted in only the protonated ligand.31'43 
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2.2 Synthesis and characterization 
2.2.1 Synthesis of the Ga(III) complex of ligand 7 
HO 
.OH 
N . Nk 







Microwave, 180 °C, 4h 
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I U °v 
NO, 
Scheme 2.1: Ga(III) complexation with ligand 7 
Ligand 7 (as an HC1 salt from its diethyl ester) was dissolved in H2O and to this 
solution an aqueous solution containing an equimolar amount of Ga(NC>3)3 • H2O was 
added. The pH of the resultant homogenous solution was adjusted to pH 3.6 with 
aqueous NaOH. After this the reaction was run in a closed (10 mL) microwave vessel for 
4 hours at 180°C (Scheme 2.1). When the reaction was complete the supernatant was 
isolated from a small amount of precipitate via centrifugation. Evaporation of the 
supernatant to dryness yielded the complex as a yellow solid. The crude product was 
washed with methanol to afford the complex as a white precipitate. The resulting 
complex was then dissolved in a 80:20 methanol:water (v:v) solvent mixture and ether 
diffusion into this solution afforded colorless crystals of the complex (45%). 
Many other approaches were tried including temperature and time variations, 
protic and aprotic solvents and a variety of bases. Most of these attempts were not 
successful. The conditions described above are optimized. 
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Previously various bases were used and the reactions were carried out in a strictly 
anhydrous environment in non-aqueous solvents, using a glove box with nitrogen 
atmosphere. Both thermal heating and microwave conditions were employed. However, 
all of these attempts were unsuccessful (Scheme 2.2) 
GaCl3 
*• starting material 
Cs2C03, Na2C03, orNaOAc 
MeCN 
Microwave 130 °C, 30 minutes 
GaCl3 
*~ starting material 
Cs2C03, Na2C03, orNaOAc 
MeCN 
reflux, 8 days, N2 
Scheme 2.2: Previous attempts of Ga(III) complexation using anhydrous 
conditions and aprotic solvent 
Other complexation conditions involved using buffered aqueous media. These 
reactions were run under thermal conventional as well as microwave-assisted conditions 
(Scheme 2.3). All the thermal reactions gave no product. Reactions utilizing a 
microwave reactor at pH=4 showed promising results from mass spectral data, but 
because of significant of the citrate buffer decomposition it was difficult to isolate or 
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Ga(N03)3 x H20 
*~ starting material 
pH=4 (ammonium citrate buffer) Reflux, 8d, N2 
pH=7 (ammonium citrate buffer) Reflux, 10d,N2 
pH=l 0 (borate buffer) Reflux, 14d, N2 
Ga(N03)3 x H20 
>-
pH=4 (ammonium citrate buffer) Microwave 150 °C, 30 minutes 
pH=7 (ammonium citrate buffer) Microwave 200 °C, 30 minutes 
pH=l 0 (borate buffer) Microwave 150 °C, 40 minutes 
Scheme 2.3: Attempted Ga(III) complexation in buffered aqueous media 
Since buffer decomposition occurred, the reactions were subsequently run in 
water. Promising results were obtained at pH 3.5 at 150 °C for 30 minutes showing 
mixtures of the desired complex and starting material. This led to longer reaction times 
(30 hours) and higher temperatures (180 °C) (Scheme 2.4). It was noticed that at longer 
reaction times the pH became basic (9.2) when the reaction was complete. It is possible 
that because the starting material is a TFA salt, decomposition of TFA under such harsh 
reaction conditions was occurring, possibly releasing CF3H (pKa~29) and OH", which 
would account for the pH change. As a control, a TFA solution was placed in the 
microwave at 180 °C for 3 hours and the pH was indeed basic afterwards. HC1 salts of 
the ligand were therefore used instead to avoid this problem. Unfortunately this problem 
still persisted, though reaction times were reduced to 4 hours. 
N . N: - O H 
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^ ^ 'nTFA closed vessel 
Microwave 180 °C, 32h 
Scheme 2.4: Ga(III) complexations with ligand 7 as TFA salt 
2.2.2 Synthesis of In(III) complex with ligand 7 
The same methodology developed for the Ga(III) complexation was used to 
prepare the In(III) complex of ligand 7 (Scheme 2.5). Ligand 7 prepared from HC1 
hydrolysis of its di-ethyl-ester was dissolved in 1 mL of water and added to an equimolar 
amount of In(N03)3-5H20 in lmL of water. Aqueous NaOH was added to adjust the pH 
of the resulting clear solution to pH 3.9. The reaction was then run in a closed vessel for 
three hours in a microwave reactor at 180 °C. When the reaction was complete a very 
small amount of precipitate was removed by centrifugation. The supernatant was 
evaporated to dryness to yield a brown oily residue that solidified upon removal of 
residual solvent under reduced pressure. 
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Scheme 2.5: In(III) complexation with 7 using In(NC>3)3 
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Various attempts were tried to purify the complex but they were not successful. Along 
with the product, inorganic salts such as NaNC>3 and NaCl were found as byproducts. In 
order to simplify the reaction, InCl3 was used as the metal salt. The reaction conditions 











microwave, 180°C, 7h LXJL cr 
Scheme 2.6: In(III) complexation with 7 using I11CI3 
Another approach that was taken to purify the [In-CBE2A]+NC,3" complex was to 
use counterion exchange. Crude [InCBTE2A]+N03_ was stirred with a saturated aqueous 
solution of NH4PF6 to precipitate [In-CBTE2A]+PF6~ as a white powder (67% yield) 
(Scheme 2.7). Slow evaporation from a 1:1 acetonitrile:methanol (v:v) solution of this 






Scheme 2.7: Anion exchange using NH4PF6 
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2.2.3 Spectral data 
Solution JH and 13C{JH} NMR data 
Figures 2.02 and 2.03 show the !H and "C^H} NMR spectra of the 
[Ga-CB-TE2A]+ complex respectively. Both ]H and "Cf/H} NMR spectra reveal that 
the complex is C2-symmetrical. The proton spectrum reveals a doublet of pentets (8 
1.89) that is consistent with the equatorial protons on the p-ring carbons. The multiplet at 
8 2.42-2.54 corresponds to the axial protons of the P-carbons. The carboxylate pendant 
arm methylene protons appear in an AX pattern with an additional long-range 
1 ^ 1 
W-coupling. The C{ H} NMR spectrum reveals eight carbon resonances suggesting 
that [Ga-CB-TE2A]+ complex is C2 symmetric on the NMR time scale. A 2D-HSQC 
(Figure 2.04) experiment was performed which showed that the downfield carbon 
resonance at 62.84 ppm correlates with the diastereotopic methylene protons on the 
pendant arms. Also the p methylene protons correlate with the p carbon resonance at 
20.75 ppm. 
iiijyjwLi _>M^ 
4 .0 3 . 8 3 .6 3 .4 3 . 2 3 .0 Z .8 2 .6 2 . 4 2 . 2 2 . 0 
Figure 2.02: *H NMR (in D20 using MeCN as reference at 2.06 ppm) of [Ga-71^03 
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Figure 2.04: HSQC NMR in D20(using MeCN as reference at 1.47 ppm) of 
[Ga-7]+N03" 
The 'H NMR spectrum of [In-CB-TE2A]+N03~ (Figure 2.05) shows significant 
dynamic broadening at room temperature. Due to this significant broadening it is 
difficult to make assignments but the spectrum does show a doublet of multiplets at 8 
1.85-1.95 and a broad quartet-like multiplet at 2.47-2.61 ppm that correspond to the 
equatorial and axial methylene protons on the P-carbon respectively. 
25 
%y\ \K. 
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Figure 2.05: JH NMR (D20 using MeCN as reference at 2.06 ppm) of [In-71^03-
at 25°C 
Variable-temperature studies were performed by increasing the temperature from 
25°C to 75°C (Figure 2.06). As 75°C was approached sharpening of the peaks occurred 
and the upfield doublet of multiplet became a doublet of pentets. Also the ~ 2.5 ppm 
multiplet gained better resolution. As the temperature was increased the distinct 
downfield AB corresponding to the diastereotopic methylene protons on the carboxylate 
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Figure 2.06: Variable-temperature 'H NMR (in D20 using MeCN as reference at 
2.06 ppm) of [In-7]+N03" 
The 'H and 13C{]H} NMR spectra of [In-CB-TE2AC1] (Figures 2.07 and 2.08) 
show the same dynamic broadening observed for [In-CB-TE2A]4N03". !H NMR does 
reveal the two diagnostic upfield multiplets; the doublet of multiplets and broad multiplet 
for the equatorial and axial p-methylene protons 8 1.75-1.87 and 2.43-2.57 ppm 
respectively. This points toward the dominance of a diamond-lattice structure. The 
^Cl'H} NMR spectrum shows the P-carbon at 8 21.69 and the carbonyl carbon of the 
pendant arms at 8 175.93 as well as several broadened signals. High-temperature NMR 
experiments were performed over a range of temperatures (Figure 2.09). As the 
temperature was increased from 25 °C the peaks sharpened and once 80 °C was reached, 
I T 1 
the AX for the CH2 protons on the pendant arms became resolved. The UC{'H} NMR 
spectrum at 80 °C (Figure 2.10) clearly revealed eight carbon resonances, which is 
consistent with a C2-symmetric complex. 
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One possible explanation for the dynamic broadening observed at room 
temperature is exchange with a species that has the counterion coordinating and filling 
the seventh coordination site. It is possible that nitrate or chloride can be coming on and 
off the indium coordination sphere at room temperature but at higher temperatures it may 
completely dissociate leaving a six-coordinate complex that is C2 symmetric or the 
exchange might be fast on the NMR timescale. X-ray data have shown that the chloride 
is indeed coordinated in the solid state, confirming a seven-coordinate geometry. 
However this solid state data may not be relevant to actual solution speciation. Since 
addition of up to 50 equivalents of KC1 did not alter the appearance of the room 
temperature spectrum, it is unlikely that counterion dissociation is responsible for the 
dynamic broadening. A fluxional seven-coordinate solution species may account for this 
temperature-dependent spectral behavior (Scheme 2.8). 
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Scheme 2.8: Possible dynamic behavior of [In'7]Cl. 
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1 3 ^ f l i Figure 2.08: ,JC{'H} NMR (using MeCN as reference at 1.47 ppm) of 
[In-7]Clat25°C 
~ U _ JK ^  
_A_ JJI 
KJ VA. ._ 
1 A / L A 
J_ 
. _ * _ „ -
3 . a 3 . 6 3 . 4 3 . Z 3 . 0 2 . 8 2 . 6 2 . 4 2 . 2 2 . 0 l . B ppm 
Figure 2.09: Variable temperature 'H NMR (in D2O using MeCN as reference at 
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Figure 2.10: Variable temperature ^C^H} NMR spectra (in D20 using MeCN as 
reference at 1.47 ppm) of [In*7CI] 
Room temperature ]H and 13C{'H} NMR spectra of [In-CB-TE2A]PF6 are consistent 
with a d-symmetric complex in solution. The !H NMR spectrum (Figure 2.11) reveals 
an upfield doublet of multiplets and a quartet-like multiplet for the equatorial and axial 0-
methylene protons at 5 1.91-1.99 and 2.49-2.62 ppm respectively. The AX of the 
pendant arm methylene protons appears at 8 3.62 and 3.89 ppm. The C{ H} NMR 
spectrum (Figure 2.12) reveals seven instead of eight carbon resonances but two of the 
signals are likely isochronous making the intensity of the resonance at 5 58.92 ppm twice 
as large as the other resonances. The carbon resonances at 8 21.93 and 8 174.88 
correspond to the p-carbon and the carbonyl carbon on the pendant arms respectively. 
Interestingly there is no significant dynamic broadening observed in this case. 
This could be another indication that what was observed for the [In-CB-TE2A]NC>3 and 
[In-CB-TE2A]C1 complexes may indeed be due to anion coordination to give a seven-
coordinate solution species. In [In-CB-TE2A]PF6 where the counterion is non-
coordinating, this dynamic broadening was therefore not observed. 
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 f l Figure 2.12: JC{'H} NMR (using MeCN as reference at 1.47 ppm) of 
[In-7]+PF6" at 25°C 
Infrared and Mass Spectra 
The IR (KBr) spectram (Figure 2.13) of the [Ga-CB-TE2A]+N03" complex 
shows a band at 2970 cm" which corresponds to the CH2 stretch. There are also two 
sharp carboxylate bands at 1678 and 1650 cm"1 from the coordinated carboxylate pendant 
arms. The FAB+ mass spectrum (Figure 2.14) of [Ga-CB-TE2A]+NC>3" exhibits a major 
peak at approximately 409 which is consistent with the cation [Ga-CB-TE2A]+ and 
composition of C^HasO^NLjGa. The most abundant peak at 100% intensity is followed 
by isotopologues at 30% intensity and then 70% intensity. These are confirmed by a 
spectral simulation (Figure 2.15).60 
The [In-CB-TE2A]+Cl" IR spectrum (Figure 2.16) exhibits a carboxylate stretch 
at 1634 cm"1 and CH2 stretch at 2921 cm"1. The FAB+ Mass spectrum of 
31 
[In-CB-TE2A]+Cr (Figure 2.17) exhibits a major peak around 455 which is consistent 
with the cation [In-CB-TE2A]+ with the composition CieHisC^NJn. The peak at 455 is 
the major one at 100% intensity and the next peak is at 19.3% intensity, consistent with 
the predicted spectrum (Figure 2.18). Mass spectrometry has therefore been very useful 
in characterizing these Ga(III) and In(III) metal complexes due to the unique isotopic 
distribution of the respective metal cations. 
"b"'Y\ 
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Figure 2.13: IR(KBr) spectrum of [Ga-7]+N03 
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Figure 2.14: FAB+ Mass spectrum of [Ga-7]+N03 
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Figure 2.15: Simulated spectrum of [Ga-7]NO; 60 
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Figure 2.17: FAB+ Mass spectrum of [In-7]C1 
« £ 158 
Figure 2.18: Simulated spectrum of [In-7]C1 60 
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The [In-CB-TE2A]+PF6" IR (KBr) spectram (Figure 2.19) contains the 
carboxylate stretch at 1640 cm"1 and PF6- stretch at 835 cm"1. The FAB+ mass spectrum 
(Figure 2.20) of [In-CB-TE2A]+PF6" exhibits a major peak around 455 which is 
consistent with the cation [In-CB-TE2A]+ and the composition of C16H28O4N4U1. The 




Figure 2.19: IR(KBr) spectrum of [In-7]+PF6" 
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Table 2.1: IR data of the Ga(III) and In(III) complexes of 7 
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2.2.4 X-ray Structural Data 
X-ray structural data for [Ga-7]+N03\ [In-7]+Cl", and [In-7]+PF6" have been 
obtained. Important bond lengths and bond angles have been summarized in Tables 2.2, 
2.3 and 2.4. 
The [Ga-7]+N03_ complex (Figure 2.21) has a slightly distorted octahedral 
geometry around gallium. This cation is encapsulated within the ligand molecular cleft. 
The conformation of the ligand is a distorted diamond lattice [2323]/[2323] with the 
familiar m-folded coordination geometry. The axial and equatorial angles N-Ga-N are 
179.10 (12)° and 85.39 (11)° respectively. The axial Ga-N bond distance is 
2.065 (3) A and equatorial Ga-N bond distance is 2.086 (3) A and the average Ga-0 bond 
distance is 1.950 (2) A. Niu was able to prepare the Ga(III) complex of ligand 5, CB-
D02A, and he was able to obtain X-ray structural data for it. When comparing these two 
complexes it can be noted that in the Ga-7 complex gallium fits much better in the 
cyclam-based ligand molecular cleft than in that of Ga-5, which is cyclen-based. For 
Ga-CB-D02A the N-Ga-N axial and equatorial bond angles are 164.56 (9)° and 86.24 
(9)° respectively. The axial and equatorial Ga-N bond lengths are almost the same as for 
the Ga-7 complex, 2.078 (15) A and 2.046 (15) A respectively and the Ga-O bond length 
is of 1.942 (13) A (Table 2.2). These results show that Ga(III) is a much better fit in 
ligand 7. 
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Table 2.2: Selected bond angles (deg) and bond lengths (A) of [Ga^l^CV 
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The [In-7] CI" complex (Figure 2.22) has a capped octahedral coordination 
geometry around the indium. Ligand 7 acts as a hexadentate donor with a N4O2 donor 
set. The chloride is also coordinated giving indium a seven-coordinate geometry. 
Indium is also larger than gallium thus the fit is poorer than in the Ga-7 case. The axial 
N(2)-In-Cl(l) and the equatorial N(l)-In-N(4) angles are 160.21 (6) ° and 81.46 (11) ° 
respectively. The average In-N bond length is 2.360 (2) A and the average In-O bond 
length is 2.258 (17) A. Table 2.3 has a summary of the important bond lengths and bonds 
angles of this complex. The coordination of the chloride counterion is not surprising. It 
would be interesting to look at the coordination chemistry with a non-coordinating anion. 
Thus as mentioned above the [In-7]+PF6~ was also prepared and its structural data (Figure 
2.23) confirm a distorted octahedral complex. The crystal structure actually shows a 
dimer where two complexes are bridged through two sodium cations via both carbonyl 
oxygen atoms of the pendant arms. Ligand 7 binds to indium in a hexadentate fashion 
with a N4O2 donor set. The cation is encapsulated within the ligand molecular cleft. The 
conformation of the ligand is again a distorted diamond lattice [2323]/[2323] with a en-
folded coordination geometry. The axial and equatorial bond angles of N-In-N are 174.3 
(3)° and 80.3 (3)° respectively (Table 2.4). The average In-O bond length is 2.136 (6) A 
and the average In-N bond length is 2.231 (8) A. Comparing this structure with that of 
[In-7]+G", the cation fit is better in this case because of the lower coordination number. It 
is important to note that the [In-7]+PF6_ complex shows the best fit so far for In(III) 
compared to octahedral complexes of In-CB-cyclam (164.2° (12) axial angle and 78.8° 
(9) equatorial angle) and In-CB-cyclen (143.9° (12) axial angle and 76.7° (12) equatorial 
angle. Also when comparing this six-coordinate [In-7]+PF6- crystal structure with the 
39 
analogous [Ga-7^03 - structure, Ga(III) still fits better into the ligand molecular cleft 
due to its superior size match. The larger six-coordinate In(III) ionic radius of 0.94 A 
compared with Ga(III)'s 0.76 A accounts reasonably well for the longer observed In-0 
and In-N bond distances. 
Figure 2.22: X-ray structure of [In-7C1] 






























































































Table 2.4: Selected bond angles (deg) and bond lengths (A) of [In'7]+PF6 
2.3 Conclusion 
Three Ga(III) and In(III) complexes with ligand 7 have been prepared. 
Microwave-assisted conditions have been shown to be successful for the synthesis of 
[Ga-7^03", [In-7]+Cr and [In-7]+PF6\ All these complexes have been fully 
characterized and X-ray structural data have been obtained. In solution both the 
[Ga^^NOV and [In-7]+PF6_ complexes have C2-time averaged symmetry on the NMR 
time scale, while [In-7]+Cl" shows dynamic broadening at room temperature. This is most 
likely due to the higher coordination number in [In-7C1] as a result of chloride 
42 
coordination as confirmed in its solid-state structure. X-ray structural data further show 
that the smaller Ga(III) is a better fit than In(III) for ligand 7. 
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CHAPTER III 
KINETIC INERTNESS STUDIES OF Ga-CB-TE2A AND In-CB-TE2A 
3.1 Introduction 
Coordination chemistry plays an important role in the design of target-specific 
I f T i f T O /.I /T-l 
radiopharmaceuticals. ' ' ' When designing metal complex-based imaging agents it 
is very important to correlate aspects of their coordination chemistry with in vivo 
behavior. ' ' ' The stability of these complexes in vivo is crucial because if 
transchelation occurs the released radiometal can bind to serum proteins such as 
transferrin (Ga, In) or may build up in radiation-sensitive organs such as the bone/bone 
marrow. ' ' ' The build up of significant amounts of the radiometal in these organs 
can have harmful consequences. 
Acid-dissociation studies have been used to investigate the kinetic inertness of 
selected Cu(II) and Zn(II) metal complexes of macro-cyclic amines.31'44'65'67 Acid-
decomplexation studies of various Cu(II), Zn(II), Ga(III) and In(III)metal complexes with 
cross-bridged tetraamines have been investigated.31'43'44'46'65'67 Kinetic studies have 
shown that metal complexes of the cross-bridged ligands can demonstrate significant 
kinetic inertness as compared to the non-bridged complexes.44'46'65'66 However, kinetic 
inertness data for Ga(III) and In(III) complexes with carboxymethyl pendant-armed 
derivatives of tetraazamacrocycles are rare. Niu and Lee were able to obtain data for 
several Cu(II), Zn(II), Ga(III) and In(III) complexes of cross-bridged tetraamines (Table 
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3.1) as a useful indicator of viability of these complexes in vivo. Further studies are 
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Table 3.1: Half-lives of selected metal complexes with cross-bridged tetraamines in 
acidic media. 3 
3.2 Results and Discussion 
3.2.1 Kinetic inertness studies of Ga(III) and In(III) complexes with ligand 7 
The synthesis and characterization of [Ga-7]NC>3 was discussed in Chapter II. 
Acid-decomplexation !H NMR studies were performed in 1.02 N and 5.04 N DCI/D2O at 
25 °C and also in 1.02 N DC1/D20 at 90 °C with substrate concentrations of 21.4 mM. 
All these results showed no decomplexation for a period of at least 11 months 
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(Figure 3.01). Note that in 1.02 N DC1/D20 at 90 °C, the AX that corresponds to the 
diastereotopic protons on the carboxylate arms has disappeared. This is due to H/D 
exchange whereas at 25 °C no exchange was observed. 
d> A 
c) 




Figure 3.01: ]H NMR spectra in 1.02 N DC1/D20: a) Ligand 7 in 1.02 N DC1/D20 at 
90°C, b) Complex Ga-7 in 1.02 N DC1/D20 at 90°C, c) Ligand 7 in 1.02 N DC1/D20 at 
25°C, d) Complex Ga-7 in 1.04 N DC1/D20 at 25°C after 11 months. 
H NMR spectra of Ligand 7 and Ga-7 complex were also investigated in 5.04 N 
DCI/D2O at 25°C with substrate concentrations of 21.4 mM and again it was noticed that 
no decomplexation occurred under those conditions (Figure 3.02) either. 
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Figure 3.02: *H NMR spectra in 5.04 N DC1/D20 at 25°C: a) Complex Ga-7 
b) Ligand 7 after 11 months. 
Since these conditions were not harsh enough to obtain decomplexation data, 
NMR investigations in 4.97 N DC1/D20 at 90°C with substrate concentrations of 21.4 
mM were performed. It was observed that within 24 hours there was a 13.2% change but 
then over a period of 5 months there was only a further 3% decrease of starting material. 
These H NMR spectra were obtained over appropriate periods of time. The furthest 
upfield doublet of multiplets that corresponds to the ft-CH2-eq protons was used for 
integrations to calculate the amount of the original and the amount of "decomplexed" 
material. 
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Figure 3.03: ]H NMR spectra of Ga-7 complex in 4.97 N DC1/D20 at 90°C, time 
(hours). 
'H NMR spectra (Figure 3.03) revealed that the doublet of multiplets corresponding to 
the starting material is at -1.87 ppm. Two new additional doublets of multiplets 
appeared upfield at -1.81 and -1.73 ppm respectively after 24 hours. Figure 3.04 (a) and 
3.04 (b) shows the kinetic plot of ln(N/No) vs time where N is the concentration at time 
(t) and No is the initial concentration. The data reveals an initial drop after 24 hours and 
then equilibrium is reached because no significant change was noticed (Table 3.2 a, b). 
This suggests that we might be dealing with a first-order reaction approaching 
equilibrium. By analyzing the data during the initial hours of the experiment we can 
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obtain half-lives. The half-life for Ga-7 in 4.97N DC1 at 90°C is 161 (± 3) hours (Figure 
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Figure 3.04: Plot of ln(N/No) vs time(hours) of complex Ga-7 "decomplexation" 
data in 4.97 N DCI/D2O at 90°C: (a) approaching equilibrium; b) measuring half-life 
There are several questions that arose from these results. Why did the 
decomplexation stop after an initial period? Are there two or three species observed? If 
this was a first-order decomplexation we should observe the complexed species as well as 
the protonated free ligand. This would lead to only one new doublet of multiplets. The 
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appearance of two new doublets of multiplets implied that apart from the starting 
complex, free ligand and some other species are present. Alternatively, it could also 
mean that there is only a single new species that has a lower symmetry than C2 which 
would account for the two new doublets of multiplets. 
An experiment that was performed to try and identify the new species was by 
spiking the sample with free ligand. 'H NMR spectra (Figure 3.05) were obtained and it 
was noticed that the doublet of multiplets of the protonated ligand actually grew in the 
middle of the new two sets of multiplets. This suggested that free ligand may not be 
present in the sample. 13C NMR data (Figure 3.06) of the spiked sample were also 
obtained and it was noticed that multiple species are present along with the free ligand. 
The upfield carbon resonance at 19.88 corresponds to the p-carbon of the free ligand and 
the one at 20.90 ppm corresponds to the complex but there are other carbon resonances 
noticed between these peaks with much lower intensity. Also multiple carbonyl 
resonances are noticed which suggests that there are multiple species present. 
MALDI-TOF mass spectra were also obtained. Prior to the spiking, the sample 
mass spectrum showed only the complexed material with a major peak at 412.7 amu 
(Figure 3.07) and no free ligand peak. FAB+ mass spectrum was also obtained for this 
sample which revealed a peak with exact mass of 413 amu, consistent with the simulation 
(Figure 3.09). After spiking the sample the mass spectrum showed the complex peak at 
412.7 amu as well as the free ligand peak at 343 amu (Figure 3.08). It should be noted 
that complex [Ga-7]+ should have a major peak at 409 amu, but H/D exchange at the 
pendant arm methylenes has occurred under the reaction conditions. At time zero the AX 
of the methylene protons of the carboxylate arms were present, but after heating the 
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sample at 90°C, within 24 hours it was noticed that this AX had disappeared confirming 
H/D exchange. Simulation of the deuterated complex spectrum has been carried out 
(Figure 3.09). Also a mass spectrum of the complex in 5M HC1 indeed yielded a major 
peak at 409 amu (Figure 3.10) as expected. 
Figure 3.05: Top spectrum: *H NMR of sample spiked with free ligand 7. 
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Figure 3.06: 13C NMR of sample spiked with free ligand 7 (arrows are pointing to 
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Figure 3.07: MALDI mass spectrum of complex Ga 7 in 4.97 N DC1/D20 prior to 
spiking with free ligand 7. 
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Figure 3.08: MALDI mass spectrum of complex Ga-7 in 4.97 N DC1/D20 after 
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Figure 3.10: MALDI mass spectrum of complex Ga-7 in 5.03 M HC1. 
Similar results were obtained when the experiments were performed in 9.01 N 
DCI/D2O at 90 °C. Ga-CB-TE2A was dissolved in a 9.01 N DC1/D20 solution with an 
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initial concentration of 23.4 mM. *H NMR spectra (Figure 3.11) were taken after 
specific time intervals and the doublet of multiplets at 1.87 ppm integrated to calculate 
the amount of original vs new species. The results showed that after 24 hours there are 
again three sets of doublet of multiplets: one corresponds to the starting complex and two 
new sets belonging to an unsymmetrical species that is still complexed to gallium. This 
unsymmetrical species must be a gallium complex because mass spectral results (Figure 
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Figure 3.12: MALDI mass spectrum of Ga 7 complex in 9.01 N DC1/D20. 
Figure 3.13 shows the kinetic plot of ln(N/No) vs time where N is the 
concentration at time (t) and No is the initial concentration. The data reveals an initial 
drop of 19.7 % change over a period of 48 hours, but afterwards little further change 
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Figure 3.13: Plot of ln(N/No) vs time(hours) of complex Ga-7 "decomplexation" 
data in 9.01 N DC1/D20 at 90°C. 
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Apart from obtaining kinetic inertness data in acidic conditions, our interest was 
expanded into studying the kinetic inertness in basic conditions as well. It is very 
important to perform studies under basic conditions to observe if Ga(OH)3 precipitation 
or Ga(OH)4_ formation would occur under highly basic conditions. NMR investigations 
of Ga-CB-TE2A complex in 1.31 N NaOD at an initial concentration of 22.3 mM at 
25 °C were performed. After a period of one month no decomposition of the complex 





3 .8 3.6 3 .4 3 .2 3 .0 2 .8 2 .6 2 .4 2 .2 2 .0 1.8 1.6 1.4 1.2 pj>» 
Figure 3.14: Kinetic inertness studies of Ga-7 in 1.3 N NaOD at 25°C: a) Ligand 7, b) 
Ga-7 complex. 
As mentioned in Chapter II, two In(III) complexes with ligand 7 were also 
synthesized, [In-7C1] and [In-7]PF6. X-ray structural data revealed that [In-7C1] is a 
seven-coordinate complex while [In-7]PF6 is a six-coordinate complex. It would be very 
interesting to investigate the acid-promoted behavior of both of these complexes in order 
to correlate their structure with their kinetic inertness. Which complex will be more 
kinetically inert, the seven- or the six-coordinated one? 
56 
The acid-decomplexation studies of the [In-7C1] complex were performed in 
1.03 N DC1/D20 solution at 25°C with an initial concentration of 40.7 mM. *H NMR 
spectroscopy was used to monitor these experiments over appropriate periods of time. 
Again the upfield doublet of multiplet assigned to the fi-Cfy-eq protons was used for 
integrations to calculate the amount of original and the amount of new species. 
lU NMR spectra (Figure 3.15) revealed that the doublet of multiplets that corresponded 
to starting material is at -1.83 ppm. An additional doublet of multiplets appeared upfield 
at ~1.78 ppm even at time zero. This interpretation may be oversimplistic because all 
peaks were broadened and there may well be other species buried under them. Figure 
3.16 is a kinetic plot of In (N/No) vs time where N is the concentration at time (t) and No 
is the initial concentration. The data showed that at time zero (i.e. sample preparation 
time) there was already a 22.5 % change (Table 3.3). Within 45 minutes there was a 
40.2 % change and within two days the loss of starting material was 54.7%. Yet again 
from two days out to 50 days there was little further change occurring, with only another 
1.5% loss. This suggests that we might be dealing with a first-order reaction approaching 
equilibrium. By analyzing the data during the initial hours of the experiment we can 
obtain half-lives. The half-life for In-7C1 in 1.03 N at 25°C is 165 (± 28) minutes 
(Figure 3.16). 
Mass spectrometry was used to identify the new species. In this case a major 
peak at 455 (m/z) which corresponded to the starting complex as well as one at 343 
corresponding to the free ligand were observed (Figure 3.17). 
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Figure 3.16: Plot of ln(N/No) vs time(minutes) of [In-7C1] decomplexation data in 
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Figure 3.17: MALDI mass spectrum of complex [In-7C1] in 1.03 N DC1/D20 after 3 
months. 
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To gauge the importance of chloride on acid-decomplexation, NMR studies of the 
[In-7]PF6 complex were performed in 1.02 N DCIO4/D2O solution at 25 °C with an initial 
concentration of 41.6 mM. ]H NMR spectra were obtained over appropriate periods. 
Again the upfield doublet of multiplets corresponding to the methylene ji-CE.2-eq protons 
was integrated to calculate the amount of starting and new species. lK NMR spectra 
(Figure 3.18) revealed that the doublet of multiplets corresponding to [In-7]PF6 material 
was at ~1.87 ppm. An additional set of doublet of multiplets appeared upfield at ~1.81 
ppm after 24 hours, though there was a shoulder next to the major doublet of multiplets 
which may indicate other species buried under these resonances. Figure 3.19 is a kinetic 
plot of ln(N/No) where N is the concentration at time (t) and No is the initial 
concentration. The data showed that after 24 hours there was a 13.1 % loss of starting 
material (Table 3.4). No further significant change occurred from day one to day three, 
though after six days there is an additional 5.2 % loss. It was observed that after six days 
out to 2 months, there was no major change occurring, with only 2.3 % further loss of the 
original material. This suggests that we might be dealing with a first-order reaction 
approaching equilibrium. By analyzing the data during the initial hours of the experiment 
we can obtain half-lives. The half-life for In-7C1 in 1.03 N at 25°C is 630 (±71) hours 
(Figure 3.19). 
Mass spectrometry was again used to identify the new species. A major peak at 
455 (m/z) which corresponds to the complex was observed, but no free ligand peak at 343 
amu was found (Figure 3.20). 
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Figure 3.19: Plot of ln(N/No) vs time(hours) of [In'7]PF6 "decomplexation" data in 
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Figure 3.20: MALDI mass spectrum of complex [In-7]PF6" in 1.02 N DC104/D20. 
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3.3 Summary and Discussion 
The acid-decomplexation studies of [Ga-7]NC>3, [In-7C1] and [In-7]PF6 were 
investigated. For [Ga-7]NC>3 experiments were performed in 1.02 N DCI/D2O at 25 °C 
and 90 °C as well as 5.04 N DC1/D20 at 25 °C. All these results revealed that no 
decomplexation had occurred after a period of 11 months. In order to obtain useful half-
life data for this complex, experiments in 4.97 DCI/D2O at 90 °C were performed. These 
suggested that the reaction might be a first-order approach to an equilibrium. The half-
life for this reaction is 161 (±3) hours. After plotting the data it was observed that there 
is a 13.2 % "decomplexation" after a period of 24 hours, an equilibrium being established 
between the starting material and a new unsymmetrical species. There was no further 
change over a period of 5 months. The equilibrium is apparently established between the 
starting complex which is C2 symmetric (gives rise to only one upfield doublet of 
multiplets) and another complex with lower symmetry (which would account for two 
upfield sets of doublet of multiplets). One possibility is that one of the arms may be 
uncoordinated with chloride filling the empty coordination site. The sample was spiked 
with free ligand and *H NMR results suggested that the new species observed was not 
free ligand. Further mass spectral data also confirmed that no free ligand was present. 
Acid-decomplexation studies of [Ga-7]NC>3 were also performed in 9.01 N 
DCI/D2O at 90 °C. The data suggested that this again be a first-order reaction 
approaching equilibrium. There was a 19.7 % change over 48 hours, but afterwards there 
was no further change, suggesting that an equilibrium has been established. Again the 
equilibrium is established between the original complex and an unsymmetrical Ci 
complex. 
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The acid-decomplexation studies of the [In-7C1] complex were performed in 1.03 
N DCI/D2O solution at 25°C. The data suggested that this again may be a first-order 
reaction approaching equilibrium. At time zero there was already a 22.5 % change, and 
within two days the decrease of the starting complex reached 54.7 %. After two days out 
to 50 days, there was very little further change occurring. The half-life for this reaction is 
165 (± 28) minutes. Mass spectrometry revealed a major starting complex peak at 455 
(m/z) and also one at 343 corresponding to the free ligand. This confirms partial acid 
decomplexation only of the starting complex. 
The acid-decomplexation studies of the [In-7]PF6 complex were performed in 
absence of chloride in 1.02 N DCIO4/D2O solution at 25°C. The data for this complex 
again suggested a first-order reaction approaching equilibrium with the half-life of this 
reaction being 630 (± 71) hours. After 24 hours there was 13.1 % loss of starting 
material but from then till 2 months later less than 8% further loss occurred. These 
studies were performed in the absence of chloride while no free ligand is observed. Mass 
spectra also revealed a major starting material peak at 455 (m/z) but no free ligand. It is 
possible that one arm has dissociated from the indium coordination sphere and a water 
molecule is filling the sixth coordination site or simply a lowering from C2 to Ci 
symmetry of the complex without pendant arm dissociation had occurred. 
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3.4 Conclusion 
The data for the [Ga-7]N03 complex suggested that this complex is remarkably 
stable under very acidic conditions even at high temperature. The data for [In-7C1] and 
[In-7]PF6 showed that in absence of chloride [In-7]+ is more kinetically inert than 
[In-7C1]. For [In-7C1] in DC1, actual decomplexation to free ligand was confirmed by 
mass spectral data. These results can be correlated to the solid state structures of the two 
In(III) complexes. Comparing the six-coordinate [In-7]PF6 complex geometry to the 
seven-coordinate [In-7C1] geometry, the cation fit is significantly better in the former 
because of its lower coordination number. Finally, both of these In(III) complexes are 
less kinetically inert than [Ga-7]NC>3 complex since Ga(III) is a clearly better fit for 
ligand 7 than In(III). 
3.4 Experimental section for kinetic studies 
Complexes used for acid decomplexation studies were: [In-CBTE2AC1], 
[In-CBTE2A]PF6, and [Ga-CBTE2A]N03. These complexes were prepared according to 
the procedures described in Chapter V. Proton NMR spectra of these complexes 
recorded at specific time intervals were used to monitor their decomplexation in acidic 
media 
(1.02 N, 4.97 N, 9.01N DC1/D20 and 1.03 N DC104) at room temperature and 90°C. 
All sample solutions of the [Ga-CBTE2A]NC>3 complex were securely-sealed using 
Wilmad screw-cap NMR tubes. For acid-promoted studies of the [Ga-CBTE2A]NC>3 
complex in 1.02 N, 4.97 N, at 25°C and 90°C, substrate concentrations were 21.4 mM. 
For acid promoted studies of the [Ga-CBTE2A]N03 complex in 9.01N DC1/D20 at 90°C 
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substrate concentrations were 23.4 mM. Initial concentration for [In-CB-TE2AC1] acid 
decomplexation in 1.05M DC1 at 25°C was 40.7mM. Initial concentration for [In-CB-
TE2A]PF6 acid decomplexation in 1.05M DC104 at 25°C was 41.6mM. Regular capped 
NMR tubes were used for this experiment sealed with parafilm and teflon tape. 
[In-CBTE2AC1] acid-promoted studies at 25°C were directly acquired on the 500 MHz 
NMR spectrometer (Varian Inova-500). Other high-temperature data were collected on 
batch samples placed in a constant-temperature water-bath. The integration of the 
decreasing signals for the complexed material versus the increasing signals for the new 
species were used to monitor the decomplexation. 
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CHAPTER IV 
OPTIMIZING MICROWAVE-ASSISTED COPPER(II), GALLIUM(III) AND 
INDIUM(III) COMPLEXATIONS WITH CROSS-BRIDGED TETRAAMINE 
LIGANDS 5-7 
4.1 Introduction 
The application of microwaves to synthetic chemistry is a research area that has 
attracted a large amount of attention in the past fifteen years.68"74 In 1986 Gedye, 
Giguere and Majetich were the first to report the use of microwave in accelerating 
organic reactions.75'76 After these reports in the late 1980s and early 1990s there was still 
a lack of interest. This can be attributed to the lack of control and reproducibility and 
also with the lack of understanding of the basics of microwave dielectric heating.77"81 
There were also many concerns regarding flammability of organic solvents in a 
microwave field and the lack of available systems to control pressure and temperature. 
There has been an increase of publications since 1995 on microwave-assisted organic 
synthesis (MAOS) due to the development of application-optimized microwave 
instruments designed with adequate temperature and pressure control compared to the 
modified domestic microwave ovens used in the 1980s.77"81 Many research facilities and 
academic research groups began using MAOS as an advanced technology for efficient 
77 R1 
synthesis resulting in shorter reaction times and higher yields. 
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Microwave radiation is electromagnetic radiation in the frequency range of 0.3 to 300 
GHz. The mechanism by which matter absorbs microwave energy is called dielectric 
heating, thus the mobility of the dipoles and the ability to orient them according to the 
direction of the electric field is very important. Molecules that have permanent dipole 
moments are able to align themselves through rotation completely or at least partly with 
f*R 70 79 89 89 
the direction of the field. ' ' ' ' Phase shifts and dielectric losses are the results. Field 
energy is transferred to the medium and is converted to kinetic or thermal energy. 
Molecular friction is often cited as a model for this behavior.68'70'72'82'82 For polar 
AC nc\ TJ QO fio 
substances dielectric losses are observed in the microwave range. ' ' ' ' For example, 
the water molecule will rotate due to the fast-changing electric field of the microwave 
radiation. Due to this process, "internal friction" takes place in a polar medium which 
leads to a direct and almost even heating of the reaction mixture.68'70'72'82'82 Because the 
change in polarity of the electric field is faster than the rotation rate of the water 
molecules around its dipole centre, a phase shift occurs and energy is absorbed from the 
electric field.68'70'72'82'82 
Synthetic organic chemistry reactions are typically carried out by conductive 
heating with an external heating source (i.e. oil baths). This is a slow method to transfer 
energy into the system, since it depends on the thermal conductivity of the various 
materials that have to be penetrated, and results in the temperature of the reaction vessel 
/•\8 70 79 89 8^ 
being higher than that of the reaction mixture. ' ' ' ' Microwave irradiation produces 
efficient internal heating (in-core volumetric heating) by direct coupling of microwave 
74 84 8^ 
energy with the molecules that are present in the reaction mixture. ' ' The observed 
rate accelerations when using microwaves compared to oil bath experiments have led to 
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the development of terminology such as "specific" or "non-thermal" microwave 
7 A HA & S 
effects. ' ' Most people in the scientific community now agree that in the majority of 
cases the reason for the observed rate enhancements is a purely thermal/kinetic effect; 
that is, a consequence of the high reaction temperatures that can rapidly be attained when 
n-i nA a A o r 
irradiating polar materials in a microwave field. ' ' ' For example, a reaction mixture 
using water or methanol, which are high microwave absorbing solvents, can be rapidly 
superheated at temperatures higher than 100 °C above their boiling points when irradiated 
under microwave conditions in a sealed vessel.73'74'84'85 These temperature profiles are 
difficult to be achieved and reproduced by standard thermal heating. Dramatic rate 
enhancements have been observed for reactions performed in high temperature 
microwave-heated processes versus the standard thermal heating processes. Baghurst 
and Mingos have used the Arrhenius equation ((k=Aexp(-Ea/RT)) to rationalize these 
enhancements.73 Based on this equation they observed that a transformation that requires 
68 days to reach 90% conversion at 27 °C, will show the same degree of conversion 
within 1.61 seconds when performed at 227 °C.73 The rapid heating and extreme 
temperatures observed in microwave chemistry means that many of the reported rate 
enhancements can be rationalized by simple thermal/kinetic effects. ' ' ' 
As described in Chapter II our interest in microwave chemistry developed when 
we were faced with the excruciatingly slow kinetics of Ga(III) and In(III) complexations 
with ligand 7. Indeed our results show that microwave-assisted conditions have 
enhanced the reaction rates and ultimately gave successful complexations versus the 
unsuccessful thermal reactions. These slow kinetics were also noticed with Cu(II) 
complexations of our cross-bridged ligands. As mentioned in Chapter I, one major goal 
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of this research is to use the ligands as bifunctional chelators for diagnostic PET imaging. 
Rapid complexation is a concern when radiolabeling is performed. 64Cu has a desirable 
half-life for our purposes but faster radiolabeling would be a significant advantage. After 
the 1986 reports about using microwaves in organic reactions, the first successful 
microwave-accelerated radiopharmaceutical syntheses in solution were reported by 
Hwang et al. The importance of generating an intense microwave field in samples led 
to the first use of a single-mode cavity to perform these transformations in solution. 
Monomodal devices designed for the space limitations of radiolabeling environments 
7Q 8 7 Q7 
were also constructed, some of which have subsequently become available. ' " There 
have been a few reports on using microwaves for radiolabeling and there are significant 
advantages related with this such as shorter reaction times and higher radiochemical 
7Q R7 QO 
purity. ' " Furthermore some reactions are only achievable using microwave heating. 
Also, these microwave-assisted conditions have shown that the amount of starting 
material required driving the pseudo-first order labeling reaction could sometimes be 
reduced, which can save precious precursors and simplify clean-up procedures and 
70 R1 09 
decrease competing reactions at other reactive sites in the starting material. ' 
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4.2 Synthesis of Cu(II) complexes with ligands 5-7 
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Figure 4.01: Cross-bridged ligands 5-7 
The Cu(II) complexations with ligands 5 and 6 were previously performed by Niu 
and the Cu(II) complex with ligand 7 was prepared by Wong. These reactions were run 
in organic solvents and for ligands 5 and 7 (Figure 4.01) a base is needed to assist 
deprotonation of the ligand for effective complexation. Our goal is to ultimately be able 
to run these reactions in aqueous buffered media and realize shorter reaction times 
especially considering possible biological applications. Thus our interest expanded to 
investigating these complexations using microwave-assisted conditions. The first Cu(II) 
complexation that was investigated was with ligand 7. 
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Scheme 4.1: Cu(II) complexation with ligand 7 using microwave-assisted conditions 
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The reactions were run in aqueous buffered media using 0.2 M aqueous citrate buffer at 
pH 6.31. Ligand 7 was dissolved in this citrate buffer solution. To this solution another 
citrate buffered aqueous solution containing an equimolar amount of Q1CI2 • 2H2O was 
added. The pH of the resultant blue homogenous solution (19mM) remained at 6.31. The 
reaction was run in the microwave closed-vessel with simultaneous cooling for 10 
minutes at 80 °C (Scheme 4.1). When the reaction was complete the supernatant was 
analyzed using UV-Vis spectroscopy (Figure 4.02). These spectra showed a A^x at 642 
nm, which is consistent with the authentic complex. These results have been the most 
successful ones. Other trials were attempted to see if the reaction can proceed at lower 
temperatures. Table 4.1 is a summary of these attempts. Unfortunately, performing the 
complexation at temperatures lower than 85 °C showed incomplete results. The 
published conditions involved 95% EtOH as a solvent and also required a base like 
NaOH for deprotonation of the ligand to facilitate the complexation. The reaction also 
had to be refluxed for 2 hours. The microwave conditions are not only faster, the yields 
are also higher (85% for the microwave reaction and 61% for the conventional methods). 
The published radiolabeling was performed at 75 °C for 4 hours. Though this 
temperature is slightly lower than the microwave conditions the reaction time is 





















broad trace ~ 677 
broad trace -710 
broad trace ~ 686 
broad trace -673 
Table 4.1: Unsuccessful attempts for Cu*7 complexations at lower temperatures 
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Figure 4.02: Visible electronic absorption spectrum of Cu'7 in aqueous citrate 
buffer. 
In order to be able to mimic more closely radiolabeling conditions, increasing 
ratios of ligand to metal were explored. These reactions led to decreasing complex 
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concentrations, which made the results hard to monitor using UV-Vis spectroscopy. 
HPLC was thus employed, because it offers better sensitivity compared to UV-VIS. The 
HPLC conditions and the detection wavelength were the same for all the reaction 
mixtures analyzed. The absorbance window was changed from sample to sample in order 
to see clearly whether or not the complex formed. The following conditions were 
developed by Xiaoxuan Shen in the Tomellini group. 
Mobile Phase: 23/77% (v/v) Methanol/30 mM Citric acid at pH 2.36 
Flow rate: 0.4 mL/min (Pressure 99-102 bar) 
Column: Hypercarb (100 x 3mm; 5u) 
Loop size: 10 pL 
UV-VIS Detection k: 280 nm. 
Temperature: 22°C 
Retention time for Cu-CB-TE2A: 3.9 minutes 
All reactions were run closed-vessel at 85 °C for 10 minutes. The first reaction 
had a concentration of 1:10 Cu(II)/Ligand ratio (0.68mM /6.8mM) with an absorbance 
window set at 0.5 (a.u.f.s.). Also, reactions with a concentration of 1:100 Cu(II)/Ligand 
(0.068mM /6.8mM) with an absorbance window set at 0.025 (a.u.f.s.) and with 
concentration of 1:1000 Cu(II)/Ligand (0.0068mM /6.8mM) with an absorbance window 
set at 0.005 (a.u.f.s.) were performed. The reaction mixtures were injected prior to the 
reaction and no major peaks were seen. After the reaction was complete the mixture was 
injected and a peak corresponding to the product Cu-CB-TE2A appeared. A peak with 
retention time of 3.8 minutes was present in all of the above reactions, which is consistent 
with the authentic material. 
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Figure 4.03: Chromatograms of Cu-7 with: (left) 1:10 Cu(II)/Ligand ratio, (middle) 
1:100 Cu(II)/Ligand ratio, (right) 1:1000 Cu(II)/Ligand ratio with retention time of 
Cu*7 is 3.9 minutes, the first peak corresponds to the citrate (arrows are pointing at 
the product peak). 
Also reactions at 75 °C for 10 minutes were tried at lower concentration. The reaction 
mixture was injected prior to the reaction and no major peaks were seen. After the 
reaction was complete the mixture was injected and a peak corresponding to the Cu-CB-
TE2A appeared. The peak height was lower than expected leading to the conclusion that 
the reaction was not complete. The reaction was run for an additional 20 minutes. The 
peak height corresponding to the Cu-CB-TE2A nearly doubled proving the hypothesis 
that the reaction was not complete. Even at a total time of 30 minutes the reaction was not 
complete. 





citrate buffer pH=6.71 
Microwave, 85°C, 10min 
Scheme 4.2: Cu(II) complexation with ligand 6 using microwave-assisted conditions 
The reactions were run in aqueous citrate buffer at pH 6.71 at a concentration of 0.2 M. 
Ligand 6 was dissolved in this solution and a solution containing an equimolar amount of 
Q1CI2 • 2H2O in the same buffer solution was added. The pH of the resultant blue 
homogenous solution (20 raM) remained at 6.71. The reaction was run in the microwave 
in closed-vessel mode for 10 minutes at 80 °C (Scheme 4.2). When the reaction was 
complete the supernatant was analyzed with UV-Vis spectroscopy (Figure 4.04). These 
results showed a peak at >cmax 604 nm, which is consistent with the authentic material. 
These results have been the most successful ones. Other attempts were made at milder 
temperatures. Table 4.2 is a summary of these less successful complexations. The 
published conventional conditions were performed in refluxing MeOH for 2 hours. The 
microwave-assisted complexations were run in aqueous buffered media and the reaction 
times were much shorter. The yields were also higher (87% yield for the microwave-
assisted complexations vs. the 63% yield of the conventional method). The previous 
radiolabeling conditions for this complexation were in EtOH and NaOH was used as base 
at 75°C for 1 hour. Again although the microwave-assisted conditions were at a higher 










broad trace at 614.0 
broad trace at 607.0 
Table 4.2: Unsuccessful attempts for Cu*6 complexations at lower temperatures 
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Figure 4.04: Visible electronic absorption spectrum of CuCh'6 in aqueous citrate 
buffer. 
Different metal/ligand ratios were explored on this reaction as well. The HPLC 
conditions followed were developed by Ilia Terova in the Tomellini group 94 
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The conditions are as follows: 
Mobile Phase: 30/70 (v/v) Methanol/0.8M potassium acetate at pH 5.3 
Flow rate: 1.0 mL/min 
Column: Strong cation exchange column (250 x 4.6mm; lOu) 
Loop size: 10 uL 
Temperature: 45°C 
UV-VIS Detection I: 280 nm. 
Retention time for Cu-CB-Cyclam: 9.5 minutes 
This retention time is consistent with authentic material. All the reactions were 
done at 85° C for 10 minutes. The reaction Cu(II)/Ligand ratio is (l.OmM /lO.OrnM) 
with an absorbance window was set at 0.2 (a.u.f.s.). Also reactions with a 1 TOO 
Cu(II)/Ligand ratio (0.1 mM /lO.OrnM) and absorbance window set at 0.02 (a.u.f.s.), and 
reactions at concentration 1:1000 Cu(II)/Ligand (O.OOlmM /lO.OrnM) ratio with an 
absorbance window set at 0.002 (a.u.f.s.) were performed. A peak with retention time of 
9.5 minutes was present in all of the above reactions which is consistent with formation 
of authentic material (Figure 4.05). 
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Figure 4.05: Chromatograms of CuCh'6 with: (left) 1:10 Cu(II)/Ligand ratio, 
(middle) 1:100 Cu(II)/Ligand ratio, (right) 1:1000 Cu(II)/Ligand ratio with 
retention time of Cu*7 is 9.5 minutes, the first peak corresponds to the citrate 
(arrows are pointing on the complex peak) 
Another Cu(II) complexation investigated was with ligand 5. Usually cyclen-
based complexations are faster than the cyclam-based ones. Our interest in this 
complexation was to confirm that this reaction would be faster and in milder conditions 
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citrate buffer pH=6.61 
Microwave, 70 °C, 10 min 
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Scheme 4.3: Cu(II) complexation with ligand 5 using microwave-assisted conditions 
The reactions were run in aqueous citrate buffer at pH 6.61 with a concentration 
of 0.2 M. Ligand 6 was dissolved in this citrate buffer aqueous solution, to this solution 
an equimolar amount of Q1CI2 • 2H2O in the same buffer was added. The pH of the 
resultant blue homogenous solution (18 mM) remained at 6.61. The reaction was run in 
the microwave closed-vessel mode for 10 minutes at 70 °C (Scheme 4.3). When the 
reaction was complete the supernatant was analyzed using UV-Vis spectroscopy (Figure 
4.06). These spectra showed a A^x at 637 nm, which is consistent with the authentic 
material. These results were the most successful. Other attempts were made at milder 









Broad trace ~ 666 
Broad trace ~ 677 
Table 4.3: Unsuccessful attempts for Cu*5 complexations at lower temperatures 
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Figure 4.06: UV-Vis spectrum of Cu-5 in aqueous citrate buffer. 
These results show that the Cu(II) complexation with ligand 5 can indeed be performed 
under slightly milder conditions than the complexation with ligands 6 and 7. The 
published conditions were performed at refluxing MeOH for 8 hours using NaOH as the 
base for the deprotonation of the ligand. The microwave-assisted complexations were 
run in aqueous buffered media and the reaction times are much shorter. 
81 
4.3 Synthesis of Ga(III) and In(III) complexes with ligand 5 
The In(III) and Ga(III) complexations with ligand 5 were also investigated using 
microwave-assisted conditions. 
Ligand 5 was dissolved in H2O and to this solution an aqueous solution 
containing equimolar amounts of Ga(N03)3 • H20 was added. The pH of the resultant 
homogenous solution was adjusted to 3.71 with aqueous NaOH. The reaction was then 
run in the microwave closed-vessel mode for 30 minutes at 85 °C using instantaneous 
cooling (Scheme 4.4). When the reaction was complete the supernatant was isolated from 
a small amount of precipitate via centrifugation. Evaporating the supernatant to dryness 
yielded the complex as a yellow solid. !H NMR spectroscopy was used to analyze the 
product and the results confirmed formation of authentic material. The previous method 
was performed in MeOH with refluxing for 2 days. The microwave-assisted conditions 
showed completion of the complexation in 30 minutes at 85 °C, though the yields were 










closed vessel N N 
\ / * nTFA microwave, 85°C,30min bU. NO, 
Scheme 4.4: Ga(III) complexation with ligand 5 using microwave-assisted conditions 
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The same methodology was applied to the complexation of In(III) with ligand 5, 
which was previously reported by Lee using conventional heating. These conditions 
involved the use of NaOAc as base to assist deprotonation of the ligand with refluxing in 
MeOH for 4 days. In this work, the complexation was investigated under microwave-
assisted conditions where the reaction was run for 30 minutes at 150 °C. Ligand 5 was 
dissolved in water and to this solution an aqueous solution containing an equimolar 
amount of InCl3 was added. The pH of the resultant homogenous solution was adjusted 
to pH 3.76 with aqueous NaOH. After this the reaction was run in the microwave closed-
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Scheme 4.5: In(III) complexation with ligand 5 using microwave-assisted conditions 
Lee's attempts to obtain X-ray quality crystals of this complex were not 
successful. Many other attempts using various recrystallization methods failed. I was 
able to purify the [In-CB-D02A]+Cl" complex using counterion exchange. Crude 
[InCB-D02AfCr was stirred with a saturated solution of NH4PF6 to precipitate 
"[In-CB-D02A]+PF6" as a white powder (Scheme 4.6, Figure 4.07). Slow evaporation 
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Scheme 4.6: Counter ion-exchange using NH4PF6 
,, ,<W A / K . j i / w - , r , 
. 1 4 .2 4 .0 3 .8 3.6 3 .4 3 .2 3 .0 2 . 8 2 . 6 2 . 4 ppffl 
Figure 4.07: 'H NMR spectrum (in D20 using MeCN as reference at 2.06 
ppm) of [In-5C1] 
Figure 4.08: X-ray structure of [In-5Cl]-2NaPF6 
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X-ray structural data indicate a seven-coordinate [In-5C1] complex (Figure 4.08) 
with a capped octahedral coordination geometry around the indium coordination sphere. 
The ligand is hexadentate with a N4O2 donor set. The chloride is also coordinated giving 
indium a seven-coordination geometry. Two equivalents of NaPF6 are present with one 
sodium coordinated to the two carboxylate oxygens on the pendant arms and also bonded 
to the other sodium are two PF6~'s. Since In(III) is larger than Ga(III) the ligand cleft fit 
is slightly poorer than in the Ga-CB-D02A case. Further, in this case the In(III) 
coordination number is 7 instead of 6. The axial N(l)-In-Cl(l) and the equatorial N(l)-
In-N(2) angles are 171.61(15)°C and 77.71(19)°C respectively. The average In-N bond 
length is 2.32 A and the average In-0 bond length is 2.34 A. Table 2.3 shows a summary 
of the important bond lengths and bonds angles of this complex. 
Footnote: The X-ray study revealed a stoichiometry of "[In-5Cl]Na2(PF6)3-6H20". 
For charge balance an additional cation, most likely a proton must also be present. This 
may be on one carboxylate arm or a water of hydration. An examination of the C-O bond 


















































Table 4.4: Selected bond angles (deg) and bond lengths (A) of [In-5C1] 
4.4 Conclusion 
In this research the use of microwave-assistance for several Cu(II), Ga(III) and 
In(III) complexations with ligands 5-7 was studied. In all cases the results showed faster 
reaction times and comparable yields using the microwave reactor. Cu(II) complexations 
with ligands 5-7 achieved faster reaction times, under mild conditions that should be 
transferable to radiolabeling. Also different stoichiometrics of excess ligand to Cu(II) 
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were explored without affecting the process. The Ga(III) and In(III) complexations with 
ligand 5 were also performed using microwave-assisted conditions. The reactions times 
for these complexations were also shorter than the conventional conditions giving 
comparable yields. Finally, X-ray-quality crystals of the previously synthesized In-CB-




General Methods and Materials 
!H NMR and 13C{'H} NMR spectra were obtained from Varian Inova-400 and 
Varian Inova-500 spectrometers. Acetonitrile was used as internal reference for samples 
run in D2O. Mass spectral data were collected using a Shimadzu Axima-CFR MALDI-
TOF and a ThermoFinnigan LCQ-ESI (using positive mode) mass spectrometer at the 
University of New Hampshire. Also samples for high resolution mass spectrometry were 
sent to the University of Notre Dame where FAB+ mass spectrometry was performed. 
All reactions at reflux were run under a nitrogen atmosphere with magnetic stirring. 
Microwave reactions were performed in a CEM Discover microwave reactor in a closed 
pressurized vessel mode with power setting at 300W. Solvent removal was by rotary 
evaporation under reduced pressure and trace solvent removal from solids was by 
vacuum pump. All solvents were reagent grade and were dried as needed. Cross-bridged 
ligands were prepared according to literature procedure (Scheme 1.2). Metal salts were 
obtained commercially and used without further purification. 
X-ray crystal structures were solved by Prof. Arnold L. Rheingold and his group at UC 
San Diego. 
[Ga»7]N03. Ligand 7 (53.2 mg, 0.108 mmol) prepared from its diethyl-ester and 
followed by HC1 hydrolysis was dissolved in lmL of water and added to a solution of 
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Ga(N03)3-H20 (37.7mg, 0.147 mmol) in 1 mL of the same solvent. Aqueous 
NaOH was added to adjust the pH of the clear solution to pH 3.6. The reaction was run 
in the closed-vessel (10 mL vessel) mode for 4 h in the microwave reactor at 180 °C. 
When the reaction was complete the supernatant was isolated from a small amount of 
precipitate by centrifugation. Evaporating the supernatant to dryness yielded the complex 
as a yellow solid (70.5 mg, contaminated with NaCl and NaNOs). This crude product was 
washed with methanol to afford the desired complex as a white solid (23.3 mg, 45%). X-
ray crystals were obtained by dissolving a sample in a 80% methanol: 20% water solvent 
mixture followed by ether diffusion into this solution to yield colorless crystals. 
Elemental analysis: Found: C, 40.20; H, 5.94; N, 14.83. Calc for CieHagNsCUGa: 
C.40.70; H, 5.98; N, 14.83. IR: umax(solid, KB^/cm"1 2970, 1678, 1650, 1384. !H NMR 
(400 MHz, D20): 5H 1.89 (2H, dp, J 17.7 Hz, 2.9 Hz, p-C//e?H), 2.42-2.54 (2H, qm, J 
12.9 Hz, P-CH//„), 2.98 (2H, dd, J 14.9 Hz, 4.4 Hz), 3.09-3.25 (8H, m), 3.35-3.55 (6H, 
m), 3.62 and 3.92 (AB of apparent ABX, C//2COO, JAB 17.5 Hz, J ^ l . 5 Hz, 4H), 3.72-
3.82 (4H, m). 13C{'H} NMR (500 MHz, D20) 6C 20.75, 49.82, 51.58, 57.71, 57.99, 
59.65,62.84,174.61. 
[In»7]CI. Ligand 7 (81.3 mg, 0.166 mmol) prepared from its diethyl-ester and 
followed by HC1 hydrolysis was dissolved in lmL of water and added to a solution of 
InCl3 (40.1 mg, 0.181 mmol) in 1 mL of the same solvent. Aqueous NaOH was added to 
adjust the pH of the clear solution to pH 3.8. The reaction was run in the closed-vessel 
mode for 7 h in the microwave reactor at 180°C. When the reaction was complete, the 
supernatant was isolated from a small amount of precipitate by centrifugation. 
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Evaporating the supernatant to dryness yielded the crude complex as a white solid (93.9 
mg, contaminated with NaCl). Purification was effected by (3x3mL) hexafluoro-
isopropanol washings to yield 61.2 mg (75%) of the product as white solid after 
evaporating the supernatant to dryness. A sample of this was dissolved in hexafluoro-
isopropanol followed by ether diffusion to give colorless crystals of X-ray-quality 
crystals. Elemental analysis: Found: C, 29.96; H, 4.27; N, 7.56; CI, 11.01; F, 13.51. Calc 
for C19H30CI3 F5lnN4Na205 C, 30.16; H, 4.00; N, 7.40; CI, 14.06; F, 12.55. IR: i)max(solid, 
KBr)/cm_1 2921, 1634. 'H NMR(500 MHz, D20): 5H 1.75-1.87 (2H, dm, J 17.5 Hz, p-
CHegR), 2.43-2.57 (2H, qm, J 13.6 Hz, P-CH#ax), 2.71-2.79 (4H, m), 2.86-3.04 (6H, m), 
3.23-3.28 (2H, m), 3.40-3.57 (8H, m), 3.70-3.77 (2H, m). ^C^H} NMR (500 MHz, 
D20) 8C 21.69, 48.85, 49.48, 57.34, 57.56, 62.42, 175.93. 
[In#7]PF6. Ligand 7 (78.8 mg, 0.161 mmol) prepared from its diethyl-ester 
followed by HC1 hydrolysis was dissolved in lmL of water and added to a solution of 
In(NC>3)3-5H20 (66.4 mg, 0.169 mmol) in 1 mL of the same solvent. Aqueous NaOH was 
added to adjust the pH of this clear solution to pH 3.9. The reaction was run using the 
closed-vessel mode for 3 h in the microwave reactor at 180°C. The resulting reaction 
mixture supernatant was isolated from a small amount of precipitate by centrifugation. 
Evaporating the supernatant to dryness yielded the crude complex as a yellow residue. 
This was dissolved in lmL H2O and stirred with a lmL saturated solution of NH4PF6UI 
the same solvent to precipitate the desired product as a white powder (65.2 mg, 67% 
yield). Slow evaporation of a sample from a 1:1 acetonitrile:methanol (v:v) solution 
yielded colorless crystals suitable for X-ray diffraction studies. Elemental analysis: 
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Found: C, 23.03; H, 4.00; N, 9.08; F, 34.09. Calc for Cj6H32.5HF15InN5.5O4P2.5C, 22.79; 
H, 3.89; N, 9.14; F, 33.80. IR: umax(solid, KBr)/cm"' 1640, 835. *H NMR(500 MHz, 
D20): 5H 1.91-1.99 (2H, dm, J 18.0 Hz, p-Ci/e,H), 2.49-2.62 (2H, qm, J 12.9 Hz, p-
CHHax), 2.97-3.23 (10H, m), 3.34-3.49 (6H, m), 3.62 (2H, X of AX, C7/2COO, JAx 17.3 
Hz), 3.69-3.79 (4H, m), 3.89 (2H, A of AX, C#2COO, JAx 17.3 Hz, 2 H ) . 1 3 C { ' H } NMR 
(100.5 MHz, D20) 5c 21.93, 49.06, 51.63, 57.52, 58.92 (overlapping signals), 62.65, 
174.88. 
[Ga»5]N03. Ligand 5 (41.3 mg, 0.131 mmol) prepared from its terf-butyl-ester 
and followed by TFA deprotection was dissolved in ImL of water and added to a solution 
of Ga(N03)3-H20 (47.2mg, 0.184 mmol) in 1 mL of the same solvent. Aqueous NaOH 
was added to adjust the pH of the clear resulting solution to pH 3.7. The reaction was run 
in the closed vessel mode for 30 min in the microwave reactor at 85°C. When the reaction 
was complete the supernatant was isolated from a small amount of precipitate by 
centrifugation. Evaporating the supernatant to dryness yielded the complex as a white-
yellowish solid (52.4 mg, 87.1%). The NMR spectra of this product are consistent with 
these of the authentic material first prepared by Niu. 
[In»5]Cl. Ligand 5 (50.3 mg, 0.159 mmol) prepared from its diethyl-ester and 
followed by HC1 hydrolysis was dissolved in ImL of water and added to a solution of 
InCU (40.1 mg, 0.181 mmol) in 1 mL of the same solvent. Aqueous NaOH was added to 
adjust the pH of the clear solution to pH 3.8. The reaction was run in the closed-vessel 
mode for 25 min in the microwave reactor at 150°C. When the reaction was complete, the 
91 
supernatant was isolated from a small amount of precipitate by centrifugation. 
Evaporating the supernatant to dryness yielded the crude complex as a yellow oil (64.3 
mg, 84.7 %). Product spectra were consistent with those of an authentic material first 
prepared by Lee.44 
[In«5Cl]-2NaPF6. Complex [In»5]Cl (31.2 mg, 0.065 mmol) was dissolved in 
lmL of water and stirred with a lmL aqueous saturated solution of NfLtPFeto precipitate 
the desired product as a white powder (21.9 mg, 57.3 %). Slow evaporation of the sample 
from a 1:1 acetonitrile methanol solution yielded colorless crystals suitable for X-ray 
diffraction studies. 
[Cu»7]. Ligand 7 (14.0 mg, 0.0286 mmol) prepared from its diethyl-ester and 
followed by HC1 hydrolysis was dissolved in 0.8 mL of 0.2 M citrate buffer (pH 6.3) 
solution and added to another 0.2 M citrate buffer solution of Q1CI2 (5.6 mg, 0.0328 
mmol) in 0.7 mL with pH of the resulting homogeneous reaction mixture remaining at 
6.3. The reaction was run in the closed vessel mode for 10 min in the microwave reactor 
at 85°C. When the reaction was complete, the supernatant was analyzed by UV-Vis 
giving a X„,ax at 642 nm, (9.8 mg, 85 % when removing the solvent) which is consisted 
with authentic material. 
[Cu»6]. Ligand 6 (9.5 mg, 0.0419 mmol) was dissolved in lmL of 0.2 M citrate 
buffer (pH 6.7) solution and added to another 0.2 M citrate buffer solution of CuCL. (7.0 
mg, 0.0410 mmol) in lmL with pH of the resulting homogeneous reaction mixture 
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remaining at 6.7. The reaction was run in the closed-vessel mode for 10 min in the 
microwave reactor at 85°C. When the reaction was complete the supernatant was 
analyzed by UV-Vis with a Xmax appearing at 604 nm, (14.4 mg, 87 % when removing the 
solvent) which is consistent with that of authentic material. 
[Cu»5]. Ligand 5 (10.5 mg, 0.0271 mmol) prepared from its diethyl-ester and 
followed by HC1 hydrolysis was dissolved in 0.8 mL of 0.2 M citrate buffer (pH 6.6) 
solution and added to another 0.2 M citrate buffer solution of Q1CI2 (5.5 mg, 0.0322 
mmol) in 0.8 mL with pH of the resulting homogeneous reaction mixture remaining at 
6.6. The reaction was run in the closed- vessel mode for 10 min in the microwave reactor 
at 70°C. When the reaction was complete the supernatant was analyzed by UV-Vis 
revealing a A.max at 637 nm, (8.7 mg, 85 % when removing the solvent) which is 
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